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Continuous twin-screw melt granulation (TSMG) has been widely used for the 
last 50 years in various industrial processes. For pharmaceutical manufacturing, TSMG 
offers many advantages over continuous twin-screw wet granulation and roller 
compaction. However, TSMG is still limited since there is still a lack of understanding 
and familiarity by pharmaceutical scientists for the continuous manufacturing of tablets. 
Therefore, this dissertation aims to facilitate the broader adoption of TSMG by 
mechanistic understanding of the granulation behavior and the challenges that need to be 
concerned during the process. 
In Chapter 1, the processes, challenges, and the future of twin-screw granulation 
(wet and melt granulation) for manufacturing oral tablets and capsules are reviewed. Four 
aspects of twin-screw granulation, including (1) granule formation mechanisms, (2) 
benefit over conventional batch process, (3) process control and monitoring, and (4) 
history, recent progress, and the future will be highlighted in this chapter.  
In Chapter 2, the recent progress of twin-screw melt granulation (TSMG) will be 
reviewed. As TSMG is a solvent-free process, it is a preferable granulation method for a 
moisture-sensitive drug as compared to twin-screw wet granulation (TSWG). Therefore, 
this chapter focuses on the understanding of how the formulation and process impact the 
granule properties as well as the challenges of TSMG that is needed to be considered. 
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In Chapter 3, the effect of thermal binders (PEG, HPC, and Compritol), molecular 
weight, and binder particle size on the physicochemical properties of gabapentin 
(GABA), a thermally labile drug, in granules prepared using TSMG was investigated. It 
was found that higher degradation and crystal size reduction of GABA were observed in 
HPC-based formulation. Smaller particle size and lower molecular weight of HPC led to 
faster granule growth. The tabletability of granules was insensitive to the variations in 
particle size and molecular weight of HPC. 
In Chapter 4, the effect of screw profile and processing conditions on the process-
induced transformation and chemical degradation of gabapentin was studied. It was found 
that both the granules size and gabapentin degradant level correlated positively with the 
specific rate, the ratio between feed rate and screw speed. At the higher specific rate, the 
barrel was filled to a greater extent, enhancing the compressive forces. This resulted in 
more interaction between the powder particles, facilitating the granule growth as well as 
generating the crystal size reduction which led to more degradation. 
In Chapter 5, the difference of granulation behavior in two sizes of twin-screw 
extruder (Nano-16 and Micro-18) was investigated. It was observed that due to the 
difference in extruder geometries between the two extruders, correlations between 
granule properties and processing parameters are different. For Nano-16, DF was a 
critical parameter, where higher DF led to higher degradant levels and more compressible 
granules.  For granules prepared using the Micro-18, SME was a critical parameter, 
where a higher SME led to higher degradant level and more compressible granules. 
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1 Chapter 1: Processes, Challenges and the Future of Twin-screw 
Granulation for Manufacturing Oral Tablets and Capsules1 
1.1 ABSTRACT 
The majority of marketed tablets and capsules products are manufactured using 
granulation processes including wet, melt, and dry granulation. These granulation 
techniques are also used across many other industries, such as the food and polymer 
industries. Powders are granulated to prevent material segregation, and to improve 
powder properties )e.g., flowability and compressibility(. While other industries 
transitioned wet and melt granulation from batch to continuous processes using twin-
screw extruders in 1970s, the adoption of twin-screw granulation has been slow in 
pharmaceutical industry. As pharmaceutical scientists become more familiar with twin-
screw granulation, and with the recent interest in continuous manufacturing, an 
increasing number of process patents and products utilizing twin-screw granulation 
platform is anticipated. This article highlights four aspects of twin-screw granulation 
)TSG(: )a( granule formation mechanisms, )b( benefit over conventional batch processes, 
)c( process control and monitoring, and )d( history, recent progresses and the future. 
1.2  GRANULE FORMATION MECHANISMS: TWIN-SCREW CONTINUOUS GRANULATION 
The twin-screw extruder )TSE( is available in a variety of configurations with the 
co-rotating, intermeshing, twin-screw extruder being the most commonly used for 
granulation applications. This design of the TSE is also considered “self-wiping”, 
because the opposing surface velocities inherent with the intermeshing motion leads to 






1 Kittikunakorn, N., DiNunzio, J. C., Martin , C., & Zhang, F. (2018). Processes, Challenges, and 
the Future of Twin-Screw Granulation for Manufacturing Oral Tablets and Capsules. AAPS 
NewsMagazine, Mar(Mar), 12-18.  





The screws consist of conveying and mixing elements (Figure 1.1). Conveying elements 
transfer material along the barrel, while mixing elements contribute to both distributive 
mixing and dispersive mixing during TSG. Distributive mixing involves division and 
recombination, while dispersive mixing involves planar mixing and extensional shear 
(stretching) (Todd, 2004). Depending on their geometry, mixing elements can be 
predominately distributive, predominately dispersive, or a balance of both. Images of 






)most common mixing 
element( 
Conveying elements Mixing elements 
Figure 1.1  Illustration of various screw elements 
The TSE is regarded as a small volume, continuous mixer. A 27 mm Leistritz 
extruder at 24 L/D configuration could operate at a production rate of 15 to 30 kg/hr. The 
total free volume inside the extruder at this configuration is only about 250 mL. This 
small mixing volume and corresponding mass transfer distance improves the product 
consistency by ensuring that all granules have similar shearing history. This is why the 
term “small volume” mixer is used to describe TSE. As shown in Figure 1.2, materials 
are bounded and divided into different regions by the screw flights and barrel wall  .
Depending on the  location  relative to the barrel and screw elements, materials experience 
different intensity of mixing  in different regions  . Hi intensity mixing-gh regions are in 






Figure 1.2  Cross section view of TSE denoting different regions of mixing (courtesy of 
Leistritz) 
Twin-screw granulation has traditionally been divided into two categories: twin-
screw wet-granulation )TSWG( and twin-screw melt–granulation )TSMG(.  
1.3  TWIN-SCREW WET-GRANULATION )TSWG( 
In TSWG, granulation fluid )e.g., water or solvent, optionally containing a 
polymeric binder or foam( is introduced into the extruder via liquid injection port either 
as liquid or as foam (Sheskey, Keary, Clark, & Bahwinski, 2007).  TSWG is 
mechanistically similar to batch high-shear wet granulation. As the granulation 
progresses along the barrel in TSWG, the powder blend undergoes wetting and 
nucleation, consolidation and coalescence, and attrition processes to transform into 
granules.  Wetting and nucleation take place in conveying regions to form large, non-
uniform agglomerates. These agglomerates are sheared, fractured, and compressed. As a 
result, consolidation and coalescence take place. Granules grow denser, stronger, and 
more uniform in mixing regions )Dhenge, Cartwright, Hounslow, & Salman, 2012a, 
2012b). 
Water or solvent can be removed from wet granules via different processes post 
granulation. Large-scale fluid-bed drying is still commonly used as a batch process to dry 
the wet granules prepared using TSWG. The ConsiGma™ continuous tableting system 




modules. When drying endpoint )product temperature or residual moisture( is reached for 
one drying module, granules are discharged and a new pack of wet granules is loaded. 
Continuous dielectric )microwave( drying has also been utilized and was first disclosed in 
the continuous pharmaceutical granulation patent by scientists from Warner Lambert 
(Ghebre-Sellassie, I., Mollan, Pathak, Lodaya, & Fessehaie, 2002).  
A continuous flash drying process has been developed by Leistritz )Figure 1.3(. 
The drying process is begun in the extruder via a vent.  After discharge, hot air is then 
used to drive off the remaining residual water and to transfer them into a mill for size 
reduction.  
 
Figure 1.3  Illustration of a twin-screw wet granulation with flash drying )courtesy of 
Leistritz( 
1.4  TWIN-SCREW MELT-GRANULATION )TSWG( 
As a solvent-free alternative to TSWG, twin-screw continuous melt-granulation 
)TSMG( uses thermal binder instead of liquid binder. The process is performed with a 
higher viscosity binder at elevated temperature. Melt granulation is especially suitable for 
drugs that undergo undesired physical or chemical changes in the presence of water or 
solvent )Lakshman et al., 2011a; Vasanthavada, Wang, Haefele, Lakshman, Mone, Tong, 
Joshi, & AT, 2011(. There have been limited studies to investigate the mechanisms of 




binders turn into low viscosity liquid )e.g., polyethylene glycol and glycerol behenate( or 
viscoelastic polymer melt )e.g., hydroxypropyl cellulose( inside the extruder barrel. 
Molten thermal binders bridge the powder particles together to form larger agglomerates. 
Coating of thermal binders on the surface of granules has been observed in the lab at the 
University of Texas using Time-of-Flight Secondary Ion Mass spectrometry for the 
surface composition analysis of granules (N. Kittikunakorn et al., 2017).  
1.5 BENEFITS OF TWIN-SCREW CONTINUOUS GRANULATION OVER BATCH 
GRANULATION 
Batch high-shear granulators generally consist of mixing blades positioned inside 
large mixing chambers. The mixing and agglomeration occur at the high shear zones, 
such as those located between the tips of the rotating blades and the wall of mixing 
chamber for high shear granulator. On the other hand, for TSG, different stages of the 
granulation process take place at different screw segments.  
Batch granulation is operated under the globally starved (the extruder barrel is at 
30 to 70% filled during processing) and unpressurized condition. Even though the TSE is 
operated under globally starved conditions, processing section of a TSE consists of both 
starved (partially filled in conveying elements( and pressurized )fully filled in mixing 
elements) segments dictated by the screw elements )White & Bumm, 2010(. Powder is 
randomly subjected to the high shear zone in a batch granulator, potentially resulting in 
non-uniform mixing dynamics. In TSG, the material is forced through a sequence of 
starved and pressurized zones. As a result, granules prepared using TSG have a more 
uniform mixing history, where incoming blend is processed in a principle of first-in, first-
out with a given residence time distribution. This allows the system to be able to operate 
in a state of control and to ensure the consistent quality of granules )Chen, Zhu, Zhang, & 
Qiu, 2016; White & Bumm, 2010(. 
Three distinct advantages of TSG are (1) more homogeneous distribution of drug, 
excipient, and binder solution; (2) reduced level of binder solution to achieve desired 




order of about 10 seconds for TSG. In comparison, granulation time for a batch process is 
on the order of minutes. This shorter processing time makes it feasible to explore high 
processing temperatures, that are not practical for batch process. 
Beside the improved quality of granules, TSG provide the following benefits 
when utilized as a continuous process )Lodaya, Mayur, Mollan, & Ghebre-Sellassie, 
2003(.  
1. Lower level of binder solution is needed 
2. Smaller production facility and less capital investment 
3. Modular construction allows flexibility in configuration of processing section 
4. On-line and real-time monitoring of product quality rather than the post-
production testing 
5. More efficient manufacturing with shorter production cycle, and lower product 
cost 
6. Simpler process optimization and scale up 
7. Use of the same equipment train for a much broader production volume and 
quicker response to changes in market demand 
1.6 PROCESS CONTROL AND MONITORING 
A TSE line consists of drive section (motor and gearbox), process section  (barrel 
and screw), and electrical and control panel. TSE is starve-fed with output rate control by 
feeder. The energy required to transform the powder blend to granules predominately 
comes from the mechanical energy input by the motor via rotating screws into the 
material. Heat conducted from barrel can also play a significant role, especially for small-
diameter extruder. Modular design of barrel and screw makes TSE an extremely versatile 
granulator. Screw elements and barrel design at any given segment can vary to 
accommodate various unit operations such as direct powder feeding, powder side 
stuffing, liquid injection, conveying, mixing, venting, and devolatilization (removal of 




Key processing variables include screw speed, barrel temperature, and feed rate. 
Screw speed is controlled by a variable speed AC drive, motor, and gearbox. Generally, 
screw speed is set between 50 to 1000 rpm. Heating and cooling of barrel is controlled by 
cartridge heaters and cooling liquid such as a water/propylene glycol mixture.  
Temperatures also can be set by liquid temperature control units, as required in explosion 
proof rated environments. For wet granulation, barrel temperature is set at or slight above 
the ambient temperature. For melt granulation, barrel temperature is set above the melting 
and glass transition temperature of thermal binders, and is typically in the range of 80 to 
130C. Feeding of powder and binder solution is controlled using loss-in-weight powder 
feeder (with the entire feeder and material are continuously weighed, the feeder speed is 
adjusted automatically to achieve the target feed rate) and pump )gear or peristaltic pump 
for liquid and side-stuffer for foam(, respectively. Twin-screw continuous granulation 
operates in an open-end discharge mode. A restraining plate or outboard bearing is used 
to prevent the screw from moving axially without obstructing the granule flow.   
Precise process control to ensure consistent product quality requires the 
monitoring of the process parameters at different locations along the barrel. The 
parameters include temperatures, pressure, and torque. Thermocouple or infrared probe 
can be used to monitor the temperature of the material. Specific mechanical energy 
(SME), the amount of motor power input into each kg of material processed, could be 
derived from the motor torque readout.  However, SME is not as critical as that for melt 
extrusion process, due to the lower energy-space, at which granulation operations are 
conducted. Because of multifactor nature of TSG process, multivariate analysis can be 
performed to understand the effect of processing variables and to identify key risk 
factors. 
Process analytical technology (PAT) should be implement to monitor the 
properties of granules on-line and in real time. Raman and near infrared spectroscopy 
have been applied to monitor drug and water content. Acoustic emission is a non-invasive 




monitoring technologies, such as the Eyecon™ imaging system, can also be used to 
assess granulation characteristics (Kumar et al., 2015a). 
1.7 HISTORY, RECENT PROGRESSES AND THE FUTURE IN PHARMACEUTICAL 
APPLICATION 
The food and polymer industries were dominated by products manufactured by 
high-shear batch granulation into the 1960s. The transition to TSG to enable continuous 
manufacturing in 1970s was based on the improved “product uniformity” and “mixing 
quality” )Martin, 2016(. Application of TSWG to prepare pharmaceutical dosage forms 
was first reported by Gamlen and Eardly in 1986 to improve compaction properties of 
acetaminophen. Granules containing 80% acetaminophen were prepared. The granulation 
process was significantly facilitated with the presence of hypromellose in binder solution 
)Gamlen, M. J. & Eardley, C., 1986(. In 2002, Ghebre-Sellasie and his colleagues at 
Warner Lambert filed the first patent on continuous pharmaceutical wet granulation using 
TSE.  The inventor disclosed a continuous granulation line consisted of twin-screw 
granulation, milling )optional(, microwave drying, and dry milling. The process was 
successfully demonstrated at 15 kg per hour output rate (Ghebre-Sellassie, I. et al., 2002). 
A significant amount of research in TSWG was pioneered by Dhenge’s research 
team at University of Sheffield, United Kingdom and Thompson’s research team at 
McMaster University, Canada. They have conducted extensive study in the granule 
formation mechanisms, effect of screw design, and effect of processing parameters )e.g., 
liquid-to-solid ratio, location of liquid injection, binder concentration, and degree of fill( 
(Dhenge et al., 2012a, 2012b; Dhenge et al., 2010; Thompson, 2015b). 
Eucreas® tablets, immediate-release tablet of metformin and vidagliptin, is the 
first commercial product prepared using TSMG. The product was developed at Novartis. 
Metformin hydrochloride granules are prepared using TSMG. Hydroxypropyl cellulose is 
used as the thermal binder. The temperature of the extruded granules is about 140 to 160 
C )above the softening temperature of hydroxypropyl cellulose and below the melting 




From a theoretical perspective, it is possible that melt granulation is a viable 
alternative to roller compaction process. Roller compaction )RC( is the most common 
granulation process to manufacture oral dosage forms. However, the well-recognized 
problems of RC include )1( a limited ability to accommodate very low or very high 
doses, )2( irregularly-shaped granules and generation of fine particles, that negatively 
affect flowability and potentially content uniformity, and )3( poor mechanical properties 
of granules for tableting )Miller, 2005(. Granules prepared with TSWG often have 
improved flow and compaction properties relative to RC. For TSMG, the particle 
“rolling” inside the extruder also has a spheronization effect on the granules. The coating 
of particles with molten binders during the extrusion process significantly improves the 
compaction properties of the granules )N. Kittikunakorn et al., 2017(. 
1.8 CONCLUSION 
The adoption, implementation, and expanded applications of twin-screw 
granulation and the potential to integrate into continuous manufacturing systems in the 
pharmaceutical industry resembles what occurred in the food and polymer industry 5 
decades ago. Valuable knowledge, technical expertise, and manufacturing experience 
gained in these industries would allow for expeditious adoption and implementation of 
this established processing technology to replace existing batch granulation processing. 
With the concerted efforts and commitment from the pharmaceutical industry, equipment 
suppliers, excipients companies, and regulatory agencies around the advancement of 
continuous manufacturing, the “evolution” of twin-screw continuous granulation is 
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2 Chapter 2: Twin-Screw Melt Granulation: Current Progress and 
Challenges 
2.1        ABSTRACT 
Twin-screw melt granulation (TSMG) is a new alternative method for granulation 
that offers several advantages over wet and dry granulation methods. TSMG has been 
rapidly gaining interest over recent years in the pharmaceutical industry. Since it is an 
inherently continuous process with controlled temperature and shear history, TSMG 
produces products with more consistent quality compared to the batch process. Studies 
have been conducted to study how various formulation and processing parameters 
influence granulation behavior and granule properties; however, there are still challenges 
that require a better mechanistic understanding to be overcome. 
This review article summarizes the current progress of TSMG, highlighting how 
various formulation and process parameters affect the physicochemical properties of 
granules. The challenges related to the process-induced physicochemical changes of drug 
substances are also discussed.  
2.2  INTRODUCTION 
2.2.1 Purposes of granulation 
Granulation is an essential process applied across different industries such as the 
pharmaceutical, plastics, chemical, and food industries. Granulation involves size 
enlargement of fine powders in which small particles are agglomerated and compacted 
into larger sizes (Ennis, 2010). In the pharmaceutical industry, granulation processes are 
applied to manufacture the majority of tablet and capsule products. The primary purposes 
of pharmaceutical granulation are (1) to improve of flowability of powder formulations 
(Cartwright, Robertson, D'Haene, Burke, & Hennenkamp, 2013), (2) to enhance the 




compressible drug (Lakshman et al., 2011a), (3) to improve the homogeneity between 
drug substance and other excipients in the formulation, (4) to control the particle size 
distribution to prevent the segregation of the material during downstream processing, and 
(5) to enhance or regulate the dissolution of drug (Ennis, 2010). 
2.2.2 Advantages of melt granulation 
Granulation processes can be categorized as wet, melt, or dry granulation. Each 
process has benefits and limitations. For wet granulation, undesired moisture-induced 
physicochemical transformations can occur. These changes include chemical degradation 
and polymorph changes of drug substance and changes in hardness and dissolution during 
storage (Lakshman et al., 2011a; Shanmugam, 2015). Dry granulation, also known as 
roller compaction, has a limited ability to process very low and high doses. Granules 
prepared with dry granulation have lower tabletability than their respective powder 
blends (Sun, C. & Himmelspach, 2006). Irregularly shaped granules and large amount of 
fines typically generated during dry granulation negatively impact the flowability and 
content uniformity (Kittikunakorn, N., DiNunzio, Martin, & Zhang, 2018).  
Melt granulation offers several advantages over wet and dry granulation, as it is 
solvent-free and the granules it produces have superior tabletability (Batra, A., Desai, D., 
& Serajuddin, A. T., 2017). Melt granulation is particularly suitable for moisture-
sensitive or highly water-soluble drugs. Melt granulation has been successfully applied at 
the commercial scale to granulate metformin (EucreasTM tablet) in order to overcome the 
challenges associated with wet granulation. Being freely soluble in water, a significant 
portion of metformin is solubilized in binder solution. The solubilized metformin does 
not fully recrystallize following drying. During storage and tableting, moisture in the 
ambient environment induces the crystallization of amorphous metformin inside the 
granules that results in poor flowability (Lakshman et al., 2011a).  
In melt granulation, nucleation of fine powders is facilitated by softened or molten 
thermal binders (Grymonpré et al., 2017). Softening or melting of thermal binders is 




2019a). Following nucleation, granule growth is promoted by the coalescence of large 
nuclei. Granules are subsequently kneaded and consolidated by applied mechanical 
forces (Ennis, 2010). The granules are cooled down to room temperature to allow bridge 
formation of solidified binder (Vervaet & Remon, 2010). Enrichment of the particle 
surface with highly compressible thermal binders has been demonstrated to effectively 
improve the tabletability of poorly compressible formulations (Lakshman et al., 2011a; 
Shi, Limin & Sun, Changquan Calvin, 2010).  
2.2.3 Transformation from traditional batch to continuous twin-screw melt 
granulation 
Despite its multiple advantages over wet and dry granulation, melt granulation has 
not been widely used due to its challenges associated with process control and process-
induced physicochemical changes. Melt granulation is traditionally performed in batch 
processes using high-shear granulators equipped with a heating jackets (Schæfer & 
Mathiesen, 1996b) or using fluid-bed granulators (Veliz Moraga et al., 2015). The poor 
and non-uniform temperature control in these batch processes limits their granulation 
performance. Binder selection is limited to only low melting-point thermal binders such 
as polyethylene glycol. Chemical decomposition of formulations can occur due to 
exposure to the elevated temperatures for extended periods. To achieve better process 
control and more consistent product quality, melt granulation based on twin-screw 
extrusion has been gaining popularity in the pharmaceutical industry over the past 15 
years. Recent advancements in melt granulation using twin-screw extruder have been 
driven by the pharmaceutical industry’s growing interest in continuous manufacturing 
and by the distinctive mixing mechanisms of twin-screw extruder, which could 
potentially overcome the challenges associated with batch melt granulation. 
Twin-screw extrusion was invented in the early 1970s for compounding plastics. 
Since then, the process has been broadly adopted in other industries such as the food, 
pharmaceutical, and chemical industries. In the pharmaceutical industry, twin-screw 




amorphous solid dispersions for bioavailability enhancement, long-acting implants, 
abuse-deterrent opioid formulations, and granules. In the pharmaceutical industry, twin-
screw granulation (TSG) was first applied by Gamlen and Eardley in 1986 to produce 
paracetamol granules using a wet granulation process (Gamlen, M. J. & Eardley, C., 
1986). In 1987, Lindberg used twin-screw extruder to prepare effervescent paracetamol 
granules via wet granulation  (Lindberg, Tufvesson, Holm, & Olbjer, 1988; Lindberg, 
Tufvesson, & Olbjer, 1987). Since Warner-Lambert’s patent filing on TSG-based 
continuous pharmaceutical granulation in 2002, TSG has gained popularity as an 
alternative for  traditional batch granulation  (Ghebre-Sellassie, Isaac, Matthew J. Mollan, 
Pathak, Lodaya, & Fessehaie, 2002).  
The advantages of twin-screw melt granulation (TSMG) over batch melt 
granulation are summarized in Table 2.1 The heating in TSMG is more efficient than that 
of batch granulation originates from both the heat conducted from the barrel and from the 
frictional heat generated between particles or at particle-screw/barrel contact surfaces. 
This distinctive heating mechanism of TSMG allows uniform heating to take place 
locally and minimizes the formulation’s exposure to elevated temperatures for extended 
period of time. Efficient heating during TSMG also enables the use of high melting point 
thermoplastic polymers (e.g. hydroxypropyl cellulose, hydroxypropyl methylcellulose, 
methacrylate copolymer, and copovidone) as thermal binders (Batra, A. et al., 2017). In 
addition, the consistency in product quality is improved due to the small mixing volume 
inside the extruder, enabling efficient mass and heat transfer (Lodaya, M. & Thompson, 
2018). The material is forced to pass through a series of starved zones (partially filled in 
conveying elements) and pressurized zones (fully filled in mixing elements) in the 
principle of first-in, first-out. This ensures that all granules experience similar shear 







Table 2.1  Differences between batch vs. continuous melt granulation 
 
Batch melt granulation 
Continuous twin-screw melt 
granulation 
Equipment High-shear granulator with 
jacketed mixing vessel 
Twin-screw extruder 
Binder Low melting point thermal 
binder (e.g., PEG or wax) 
Both low melting point thermal 
binder (e.g., PEG or wax) and 
thermoplastics binder (e.g., HPC, 
HPMC, or PVP) 
Mechanism of 
heating 
Heat conducted by the 
heated vessel 
1. Viscous and frictional heat 
dissipation by screws 
2. Heat conducted by heated barrel 
Mechanism of 
mixing 
Mixing by rotating blade Dispersive and distributive mixing 
(more extensive and effective) 
Processing time 10-20 minutes 10 seconds to 2 minutes 




Difficult to implement 
advanced control stategies  
Advanced control strategies can be 
implemented to ensure all critical 
quality attributes are within 
specification rather than process 
variables operating at steady state. 
 
TSMG has been applied to the preparation of a wide range of drug delivery 
systems, including immediate-release (Lakshman et al., 2011a), sustained-release (Patil, 
Tiwari, Upadhye, Vladyka, & Repka, 2015; Vaingankar & Amin, 2017), modified-
release (Keen et al., 2015), and taste-masking dosage forms (Upadhye, Vladyka, Repka, 
Park, & Tiwari, 2017). Furthermore, TSMG can efficiently improve tabletability even 
with low amounts of thermal binder to the extent that tablets containing up to 90% drug 
substance have been successfully manufactured using a TSMG process. High drug 
loading is especially beneficial for high-dose drugs since this leads to smaller tablets 
(Lakshman et al., 2011a; Vasanthavada, Wang, Haefele, Lakshman, Mone, Tong, Joshi, 
& AT, 2011). EucreasTM is one of the commercial products prepared using TSMG to 




problem related to the solubilization of metformin during wet granulation process 
(Lakshman et al., 2011a). 
2.3 TWIN-SCREW EXTRUDER  
The pharmaceutical industry typically uses co-rotating, fully intermeshing, twin-
screw extruders in which two parallel screw shafts rotate in the same direction (Giles, 
2005). The fully intermeshing characteristic is considered to render the screws self-
wiping, such that the flight of one screw wipes material from another screw as material is 
conveyed down the length of the barrel (DiNunzio, Zhang, Martin, & McGinity, 2012).  
Self-wiping eliminates the stagnation of the material on the screw surface and barrel wall 
and is desirable for pharmaceutical processing to maintain drug stability. The length of 
the processing section is commonly defined by the L/D ratio, which the ratio of length 
(L) to the diameter (D) of the barrel (Seem et al., 2015). Extruders with L/D ratio less 
than 40 are commonly used for pharmaceutical processing (DiNunzio et al., 2012). 
Extruder barrels are heated using internal cartridge heaters and are cooled with 
circulating water or oil (Martin, 2013b). The screws arranged on the screw shaft are 
housed and fit in the bore of the barrel, creating confined space between the screw and 
barrel wall. This confined space ensures that consistent shear is applied on the material 
and improves the mixing efficiency, resulting in a more consistent product (Keleb, 
Vermeire, Vervaet, & Remon, 2004).  
Specific functionality can be utilized along the barrel, allowing multiple-unit 
operations such as feeding, venting, liquid injection, and devolatilization to be conducted 
in a single extruder. The upstream of the barrel is typically used as a feed zone in which 
the material is introduced into the extruder (Figure 2.1). Gravimetric or volumetric 
feeders are used to precisely control the feed rate. Feeding to extruders in pharmaceutical 
processes is normally conducted in a starve-fed mode where the rate of material feeding 





Figure 2.1  Schematic diagram of twin-screw melt granulation 
There are mainly three types of screw elements used in granulation: conveying 
elements, kneading elements, and combing elements (Figure 2.2). 
Conveying element 
Mixing element 
Kneading element Combing element 
   
Figure 2.2  Screw elements for the twin-screw extruder. 
2.3.1    Conveying element 
Conveying elements are mainly used to transfer the material in the forward or 
reverse direction. They are available in various pitches, with pitch referring to the length 
between the flights along the element. Narrow-pitch conveying elements exhibit the 
slowest conveying capacity and the highest degree of  fill of channel volume (Giles, 
2005). On the other hand, wide pitch conveying elements provide the highest conveying 
capacity and operate at a lower degree of fill. They are typically used in the feed zone or 




influences the residence time. As the pitch length decreases, the residence time increases, 
and it takes more revolutions to convey material over the same axial distance (Ziegler & 
Aguilar, 2003). Since the conveying element is partially filled, the residence time in this 
zone is only affected by screw speed. An increase in feed rate, however, will result in a 
higher degree of fill without changing the residence time in this element (Giles, 2005).   
2.3.1 Mixing element 
Kneading element 
Kneading elements are used in the mixing zone to apply high-shear mechanical 
energy to materials via distributive and dispersive mixing. Distributive mixing divides 
and recombines material without changing its morphology. The materials are uniformly 
distributed without the particles being broken down. In comparison, dispersive mixing 
generates shear stress and extensional stress to overcome the cohesive forces of the 
agglomerates. Dispersive mixing can change the morphology of material and can lead to 
particle size reduction (Ghebre-Sellassie, Isaac, Martin, Zhang, & Dinunzio, 2018). 
Kneading elements are composed of individual kneading discs which are offset at 
specific offset angles (e.g., 30°, 45°, 60°, and 90°). Mixing performance is dictated by 
both offset angle (W) and disc width (S) (Figure 2.3). Larger offset angles lead to an 
increase in the opening between discs, thereby reducing the transport force (forwarding 
flow, T) and increasing the backflow (reversing flow, M). As a result, it reduces the 
conveying capacity and creates high pressure and compaction which improves the mixing 
performance (Andersen, 2018). The other aspect of kneading element geometry that plays 
an important role in mixing performance is the disc width. Narrow kneading disc width 
reduces shear in the kneading gaps as the material can more easily flow around the disc. 
As the disc width increases, the material flow is split into fewer streams which reduces 
the distributive mixing. However, the intensity of dispersive mixing (K) increases as the 
materials are prone to spread in the axial direction over the crest region as a result of the 
forces from discs upstream and downstream (Andersen, 2018; Todd, 1998b). Kneading 




element sections can be varied by adjusting the feed rate, but it is not affected by the 
screw speed. 
 
Figure 2.3  Critical parameters of kneading elements: offset angle (W), the disc width (S). 
T and M indicates forwarding and reversing flow, respectively. K represent the material 
that passes over the element crest. 
Combing element 
Combing elements are conveying elements with a series of cuts on their flights to 
create distributive mixing. The conveying capacity and mixing performance of combing 
elements are between those of conveying and kneading elements. They offer mixing with 
less mechanical shear stress applied to the material (Thompson, 2015a). Combing 
elements are used preferably  in twin-screw wet granulation because they can be used to 
facilitate liquid binder distribution in the solid powder bed or to de-agglomerate the 
granules following  kneading elements (Djuric, Dejan, 2008). However, combing 




2.4 GRANULE FORMATION MECHANISM DURING TSMG 
 
Figure 2.4  Granule formation mechanisms 
Granulation consists of three processes: (1) wetting and nucleation, (2) 
coalescence and consolidation, and (3) attrition and breakage as shown in Figure 2.4  
(Yinghe He, Lian X. Liu, James D. Litster, & Kayrak-Talay, 2010). The binder viscosity 
plays a crucial role in the wetting and nucleation process during TSMG (Monteyne, T., 
Heeze, Liza, et al., 2016). In batch melt granulation processes using high shear 
granulators, the granulation mechanism was described as either immersion or distribution 
as shown in Figure 2.5 (Schæfer, 2001). The distribution mechanism is favored when the 
binder viscosity is low or when the binder particles are smaller than solid particles being 
granulated. The immersion mechanism, on the other hand, is dominant when the binder 






Figure 2.5  Granule formation mechanism in batch melt granulation. 
Twin-screw extrusion provides superior mechanical mixing and control of heat 
and mass transfer compared to high shear granulation. It was suggested that the 
granulation mechanism in the extruder starts off with an immersion mechanism followed 
by a distribution mechanism (Mu & Thompson, 2012). At the initial stage of granulation, 
the high binder viscosity restricts the spread of the binder. The solid particles are 
captured by the softened binder particles. Once the material is exposed to higher 
temperatures and more intensive mixing, binder viscosity significantly drops and 
promotes the distribution of binder on the solid surface particles. 
2.5 FACTORS AFFECTING THE PHYSICAL PROPERTIES OF GRANULES 
Several formulation and process parameters (Table 2.2) can impact granulation 
behavior during TSMG and subsequently granule properties (Monteyne, Vancoillie, 
Remon, Vervaet, & De Beer, 2016b). Various factors that significantly affect the physical 










Table 2.2  Formulation and process variables affecting the physical attributes of granules 
Factors Observation References 
Formulation composition 




Provide two opposing effects: 
1. Low MW binder promotes the binder 
distribution, facilitating the granule growth. 
2. Smaller granules are formed with lower 
MW of binder as a result of weak and 
fragile granules which easy to break.  
(Kittikunakorn, Nada, 
Koleng, Listro, Calvin 
Sun, & Zhang, 2019; 




Crystalline binder (e.g. PEG): Solid particles are 
captured on the surface of binder droplet. The larger 
binder size is used, the large granules are formed. 
Amorphous binder (e.g. HPC): Binder with larger 
particle size requires longer time to get soften, thus 
small granules and fines are generated. 
(Kittikunakorn, Nada et 
al., 2019; Mu & 
Thompson, 2012; 




Miscible system: Less processing temperature is 
required due to plasticizing effect. Drug-binder 
interaction hinders the polymer movement which 
restrict the binder distribution. 
Immiscible system: Higher processing temperature 
is required. Binder distribution largely depends on 
the binder viscosity. 
(Monteyne, T., Heeze, 
L., Mortier, S. T., 
Oldorp, K., Nopens, I., et 
al., 2016; Monteyne, T., 
Heeze, Liza, et al., 2016) 
Process parameters 
Feed rate and 
screw speed 
Variation of feed rate and screw speed changes the 
degree of fill and SME, which can be strongly 
correlate with granules properties. However, 
different result can be observed, depending on 
machine variables. 
(Kittikunakorn, N., Sun, 
& Zhang, 2019; Liu, Y., 
Thompson, & O’donnell, 
2018; Monteyne, T., 




Processing temperature is typically set at higher 
than Tm and Tg of the binder. Higher temperature 
decreases (amorphous) binder viscosity, resulting in 
improved binder distribution. No significant effect 
is observed when crystalline binder is used. 
(Monteyne, T., 




Conveying element generates porous and fragile 
granules. More compacted and stronger granules 
are generated with kneading element. The larger 
offset angle and the wider disc width is used, the 
higher dispersive mixing is generated.  
(Djuric, Dejan & 
Kleinebudde, 2008; Mu 
& Thompson, 2012; Van 
Melkebeke, B., Vervaet, 
& Remon, 2008; 





2.5.1 Formulation Composition 
2.5.1.1 Binder properties 
Binders are usually added to formulations to overcome undesirable properties of 
granules and tablets such as poor compressibility or inadequate granule strength. Binders 
accomplish this by improving the cohesiveness to the powder, thereby creating strong 
inter-particulate bonding to form granules. The polymers that can be used as a binder for 
TSMG are broadly categorized into two groups, hydrophilic and hydrophobic binders 
(Table 2.3). Binder selection is generally based on the formulation requirement. 
Hydrophilic binders such as polyethylene glycol (PEG), polyvinyl pyrrolidone (PVP), 
hydroxypropyl cellulose (HPC), and hydroxypropyl methylcellulose (HPMC) are used 
for immediate-release formulation. Hydrophobic binders such as ethylcellulose (EC) and 
waxes are used for modified release dosage forms. For immediated-release dosage forms, 
hydrophilic binders can be classified into two types: low-melting point binders with low 
viscosity (e.g. PEG) and thermoplastic binders with high viscosity (e.g. HPC, HPMC). In 
batch melt granulation processes, the selection of binders is limited to the low-melting 
point thermal binders. Due to the distinctive melting and mixing mechanisms of TSMG, 
thermoplastic binders with high melting points or glass transition temperatures can be 
used (Batra, A. et al., 2017).  
 Typically, the processing temperature is set above Tm or Tg of the polymeric 
binders but below Tm of the drug substance to maintain the drug in its crystalline state in 
order to minimize physicochemical changes. Distribution of molten binders on the 
surface of solid particles is driven by both mixing and compaction during TSMG. 
Different binders or the same binder with different particle sizes or molecular weights 
may exhibit different thermomechanical behavior under the elevated temperature and 







Table 2.3  Polymers that is used as a binder in TSMG. 
1 (Monteyne, T., Vancoillie, J., et al., 2016b), 2 (Mu & Thompson, 2012), 3 (Van Melkebeke, Barbara, Vermeulen, Vervaet, & Remon, 
2006), 
 4 (Monteyne, T., Heeze, Liza, et al., 2016), 
 5 (Tan, David Cheng Thiam et al., 2014), 6 (Monteyne, T., Adriaensens, P., et al., 
2016), 7 (Patil et al., 2015), 8 (Keen et al., 2015), 9 (Batra, A. et al., 2017),  10 (Weatherley, Sharleen, Mu, Thompson, Sheskey, & O' 
Donnell, 2013), 11 (Vasanthavada, Wang, Haefele, Lakshman, Mone, Tong, Joshi, & AT, 2011), 12 (Verstraete et al., 2016),  13 
(Monteyne, Tinne et al., 2016), 14 (Grymonpré et al., 2017), 15 (Xu, Nahar, Dave, Bates, & Morris, 2018),  16 (Monteyne, T., Heeze, 
L., Mortier, S. T., Oldorp, K., Nopens, I., et al., 2016), 17 (Kittikunakorn, Nada et al., 2019), 18 (Kittikunakorn, N., Sun, C. C., et al., 
2019), 19 (Steffens & Wagner, 2019a) 
 
Polymer Grade Tg (°C) Tm(°C) 
Hydrophillic polymer  
Polyethylene glycol (PEG) PEG 4001,3 - 53 
 PEG 33502,7,10 - 62 
 PEG 40003 - 65 
 PEG 80002,10,17 - 63 
Polyethylene oxide  PEO 1M5,6,9  65-70 
Poloxamer Kolliphor® P40719 - 56 
 Kolliphor® P1889 - 52-57 
Polyvinyl caprolactam-polyvinyl 
acetate-polyethylene glycol graft 
copolymer 
Soluplus®1,4,13,14,16 70 - 
Polyvinylpyrrolidone Kollidon® 12 PF9 72 - 
 Kollidon® 309 160 - 
Vinylpyrrolidone-vinyl acetate 
copolymer  
Kollidon® VA649,14 108 - 
Hydroxypropyl cellulose  Klucel® ELF17 120 - 
 Klucel® EXF9,17,18 120 - 
 Klucel® EF7 120 - 
 Klucel® HF11 130 - 
Hydroxypropylmethyl cellulose  HPMC K4M, AffinisolTM 4M5,14 96 - 
 AffinisolTM 15LV14 97 - 
 HPMC K100M11 175 - 
Methylacrylate copolymer Eudragit® EPO9,14 45-53 - 
 Eudragit® L100-559 110 - 
Hydrophilic thermoplastic 
polyurethane (TPU) 
TecophilicTM (SP60D60)12 - 71 
Hydrophobic polymers 
Glyceryl behenate  Compritol® ATO 8885,8,17 - 70 
Glyceryl palmitostearate  Precirol® ATO55 - 52 
Stearaic acid6  - 69 
Ethyl cellulose  Ethocel®7,11 133 - 
Hydrophobic thermoplastic 
polyurethane (TPU) 




2.5.1.1.1  Binder Molecular Weight 
The binder molecular weight was reported to exhibit two opposing effects on the 
granule size. On one hand, lower molecular weight results in weak and fragile granules 
which are more susceptible to breakage during the attrition and breakage steps. On the 
other hand, the low molecular weight facilitates granule growth by exhibiting more 
efficient spreading on the surface of solid particles during the wetting and nucleation 
steps. Therefore, the overall effect of binder molecular weight on the granule size is 
dependent on the formulation and the process.  
Larger caffeine-HPMC granules were observed when HPMC of higher molecular 
weight was used (HPMC 4M) (Liu, Y., Thompson, & O’donnell, 2018). Higher viscosity 
resulted in stonger bridges between solid powders, thereby generating larger granules. 
Consistent results were observed by Mu & Thompson, in which the granule size of 
lactose increased with higher molecular weights of PEG (PEG 3350 vs PEG 8000) (Mu 
& Thompson, 2012).  The opposite effect was found in gabapentin-HPC granules, in 
which larger granules were formed when HPC of a lower molecular weight grade 
(Klucel® ELF) was used due to the more efficient binder distribution. (Kittikunakorn, 
Nada et al., 2019). However, in terms of the effect of binder molecular weight on the 
tabletability of granules, no significant difference was observed when different molecular 
weights of PEG (Mu & Thompson, 2012) and HPC (Kittikunakorn, Nada et al., 2019) 
were used.  
2.5.1.1.2 Binder particle size  
The effect of binder particle size on the properties of TSMG granules has been 
reported. Mu and Thompson observed that the final granule size of lactose becomes 
larger with an increasing particle size of PEG, suggesting that the immersion mechanism 
is dominant (Mu & Thompson, 2012). With this mechanism, once the solid binder melts, 
nuclei of solid powders are captured on the surface of binder droplet. The larger particle 
size of binder creates larger binder droplets. Therefore, a positive correlation is observed 




the opposite effect was observed with thermoplastic binder (e.g., HPC) in which binder of 
larger particle sizes requires longer residence times inside the barrel to soften. Therefore, 
when HPC of larger particle size was used (Klucel® EF), more fines or under-granulated 
granules were obtained as compared to the formulations consisting of finer HPC 
(Klucel® EXF). In both studies, the particle size of binders had no effect on the 
tabletability of gabapentin granules.   
2.5.1.2  Binder and drug miscibility 
Even though twin-screw extruder is used for both TSMG and hot-melt extrusion 
(HME), the objectives of these two processes are different. HME requires good 
miscibility between drug and polymer melt in order to form a drug-polymer solution. 
Polymer typically accounts for more than 65% of the formulation in HME (Huang, Mao, 
Williams, & Yang, 2016). In contrast, the objective of TSMG is to form granules using 
molten polymer as a binder to facilitate the nucleation and agglomeration of solid 
particles. The miscibility between drug and polymer should be minimized to prevent the 
physicochemical changes resulted from the solubilization of drug in polymer melt. The 
miscibility between drug and binder can be determined using differential scanning 
calorimetry analysis (Kittikunakorn, Nada et al., 2019; Monteyne, T., Heeze, Liza, et al., 
2016), Hanson solubility parameters, and Flory-Huggins solubility parameters 
(Monteyne, T., Vancoillie, J., et al., 2016b). The level of binder is typically below 20% in 
TSMG process (Lakshman et al., 2011a). 
Monteyne et al. examined the effect of miscibility on processability and granule 
formation (Monteyne, T., Vancoillie, J., et al., 2016b). Formulations (e.g. metoprolol-
Soluplus®, acetaminophen-HPC) with good drug-binder miscibility can be processed at 
lower processing temperatures and with less specific mechanical energy. This is 
attributed to the plasticization of binder by the solubilized drug. In miscible systems, 
granule growth is more readily promoted when the nuclei collide. The nuclei are 
subsequently deformed and kneaded under the intensive mechanical mixing. However, 




together. This phenomenon hinders the polymer chain to flow independently which 
results in poor binder distribution. The binder is distributed in discontinuous patches 
rather than forming a continuous binder film, as confirmed by Rheoscope analysis. As a 
result, the lower strength of granules is produced (Monteyne, T., Heeze, L., Mortier, S. 
T., Oldorp, K., Nopens, I., et al., 2016).  
On the other hand, immiscible systems (e.g. gabapentin-HPC, cafeine-Soluplus®) 
require higher processing temperatures (above Tm or Tg of the polymer) due to the lack of 
plasticization. Because of the absence of strong drug-binder interaction, a continuous 
binder film is formed instead of a discontinuous network in the case of miscible system. 
The distribution of binder on the primary solid particles in an immiscible system largely 
depends on the binder viscosity. At higher barrel temperatures, the binder viscosity 
decreases, which facilitates binder distribution and granule growth (Monteyne, T., Heeze, 
L., Mortier, S. T., Oldorp, K., Nopens, I., et al., 2016).  
2.5.2 Processing parameters 
2.5.2.1 Feed rate and screw speed 
Feed rate and screw speed are critical parameters that affect the physicochemical 
properties of granules. Varying feed rate and screw speed can alter the system parameters 
such as residence time, degree of fill, and specific mechanical energy (SME) (Todd, 
1998b). Quality attributes of granules are highly correlated with these systems 
parameters. These parameters are often kept constant during process scale-up. Degree of 
fill represents the present volume occupied by the material out of the total free volume 
inside the barrel. SME represents the amount of energy generated by the motor that 
inputs into each kilogram of the material processed (Martin, 2013b). The relationship of 
screw speed and feed rate with SME is represented by the following equation: 
𝑆𝑀𝐸 =  
𝑘𝑊 (𝑚𝑜𝑡𝑜𝑟 𝑟𝑎𝑡𝑖𝑛𝑔) 𝑥 %𝑇𝑜𝑟𝑞𝑢𝑒 𝑥 
𝑅𝑃𝑀 𝑟𝑢𝑛𝑛𝑖𝑛𝑔
max 𝑅𝑃𝑀





 Equation 2.1 
An increase in screw speed and a decrease in feed rate result in higher SME and 




combinations of different screw speeds and feed rates. Different correlations between 
processing parameters and granule quality attributes have been reported in literature. One 
possible explanation might be the differences in screw profile and screw geometry used 
in the studies. Screw profile and screw geometry play critical roles in determining the 
granulation behaviors and mechanisms. Higher degree of fill, achieved with high feed 
rates and low screw speeds, generate larger and stronger granules in small size extruders 
(e.g., Leistritz Nano-16 mm), while the opposite result was found in larger extruders 
(e.g., Leistritz Micro-18 mm). Kittikunakorn et al., examined the difference in the granule 
mechanisms between the Leistritz Nano-16 and the Leistritz Micro-18. The Leistritz 
Nano-16, commonly used in the early stages of formulation development, exhibits 
smaller free volume and narrower over-flight gaps. The Leistritz Micro-18 has a higher 
free volume which is usually used to support phases 1 through 3 clinical trials (0.5 to 4 kg 
per hour production rate). Due to its narrower kneading discs (2.5 mm in width), the 
Nano-16 does not provide efficient dispersive mixing to melt thermal binders. Therefore, 
higher barrel temperatures and higher degree of fill are required to form granules using 
the Nano-16, as these conditions allow greater axial compaction and more efficient 
heating by the barrel. At higher degree of fill, better interlocking between the primary 
particles was achieved. Consequently, larger granules with better tabletability are 
produced. A similar correlation was also found in granules processed by using the Prism 
Eurolab 16 twin-screw extruder (Monteyne, T., Vancoillie, J., et al., 2016b).  
Conversely, the opposite correlation between processing parameters and granule 
properties was observed in the Leistritz Micro-18. The kneading discs for the Leistritz 
Micro-18 are wider (5 mm) and provide more intensive dispersive mixing. As a result, 
the energy required to melt HPC is predominately provided by the dispersive mixing of 
kneading elements. The extent of dispersive mixing is quantified by SME. Higher feed 
rates with the constant screw speed lower the specific mechanical energy applied  to the 
material, resulting in fragile granules of low tabletability. Similar observations were 
reported in TSMG of caffeine-HPMC granules using a Leistritz ZSE-HP 27 mm extruder 




lower feed rates at a fixed screw speed, which was attributed to high SME generated 
under this condition. The mechanical energy induces the interaction between particles, 
facilitating binder distribution and granule growth. Therefore, granules with improved 
tabletability are prepared at high SME conditions (low feed rate and high screw speed). 
However, high SME imposed on the material potentially affects the physicochemical 
stability of drug substance as high energy can break down drug crystals and promote 
amorphization or polymorphic transformation (Kittikunakorn, N., Sun, C. C., et al., 
2019). Therefore, SME should be optimized to be sufficient to achieve the strong 
granules but not too high as to cause the undesirable properties of granules.  
2.5.2.2 Barrel temperature 
Barrel temperature is one of the critical processing parameters during TSMG as 
the heat transfer between the barrel and formulation can play a significant role in 
granulation formation. Barrel temperature is usually set above the melting point and glass 
transition temperature of the polymer but below the melting point of crystalline drug. For 
semi-crystalline binders with low melting points and low melt viscosities (e.g., PEG, 
waxes), no significant influence on the granule (caffeine-PEG granules) properties was 
observed as the binder abruptly changes from solid to liquid once the barrel temperature 
exceeded their melting points  (Monteyne, T., Vancoillie, J., et al., 2016b). However, for 
thermoplastic binders with high molecular weights (e.g, Soluplus®, HPC, HPMC), the 
effect of barrel temperature is significant. At higher barrel temperature, the improved 
binder distribution due to lower melt viscosity induced faster agglomeration of the nuclei, 
which promoted granule growth and increased granule strength. Larger and less friable 
granules (caffeine-soluplus® granules) were then obtained at higher barrel temperature 
(Monteyne, T., Vancoillie, J., et al., 2016b).  
However, the physicochemical instability of drugs must be considered when 
choosing a barrel temperature. High barrel temperatures might lead to undesired 
physicochemical changes of drug substances. Therefore, to achieve granule growth with 




they require lower processing temperatures to melt. Pre-plasticized or in-situ 
plasticization commonly used in the HME process to decrease the polymer melt viscosity 
could be applied in melt granulation process to minimize drug degradation (Repka et al., 
2007). 
2.5.2.3 Screw configuration 
One distinctive feature of twin-screw granulation is the modular screw design.  
The sequence of different conveying and mixing elements could be designed to meet 
specific process needs. Studies have showed that screw configuration can have a 
significant effect on the size, strength, structure, and temperature of granules (Batra, A. et 
al., 2017; Mu & Thompson, 2012) Since the conveying elements do not provide intensive 
shear force, porous and friable granules are typically formed with conveying elements 
alone (Djuric, Dejan & Kleinebudde, 2008). Wide pitch conveying elements are 
positioned under the feed and vent zones to transfer the material. Narrow-pitch conveying 
elements are normally positioned upstream of kneading elements to pre-compact the 
material prior to its entry into the mixing zone (Todd, 1998b). In the mixing zone, 
mechanical energy is converted via dispersive and distributive mixing into the thermal 
energy needed to soften or melt the binders (Vercruysse et al., 2012). This results in an 
increase in granule temperature. The mixing also promotes the consolidation of nuclei 
and facilitates binder distribution. As a result, dense and strong granules are formed 
(Seem et al., 2015). However, very dense granules might not be desirable as the granules 
resist deformation upon compression, resulting in a deterioration of granules tabletability. 
Moreover, longer disintegration time and slower drug release might occur due to the 
restriction of the water penetration into dense granules (Vercruysse et al., 2012). 
Modification of the conveying element located after the mixing zone can also impact the 
final granule properties. If a narrow-pitch conveying element is used, further breakage 
and attrition can occur, and the milling process after granulation can be avoided (Van 
Melkebeke, Barbara et al., 2006). On the other hand, wide pitch conveying elements 




granule formation which can reduce the exposure time of material to high temperatures. 
However, oversized granules might be obtained, and a milling process might be required 
to achieve the optimal granule size. 
It was reported that even one mixing zone was sufficient to prepare granules with 
uniform binder distribution (Van Melkebeke, B. et al., 2008). Mu and Thompson 
characterized the properties of granules prepared with different screw configurations 
which were composed of conveying elements with an incremental number of mixing 
zones consisting of two 60° kneading elements. These three different screw 
configurations varied the level of mechanical stress and the retention time during the 
process. Oversized granules with fewer fines are generated as the number of mixing 
zones increases. However, after the granule growth reached certain threshold, further 
addition of mixing zones did not result in any significant difference in granule growth 
(comparable fraction of large granules) (Mu & Thompson, 2012). 
Offset angle and the disc width are the key parameters that control the mixing 
performance of kneading elements. The larger the offset angle and the wider the disc 
width, the more aggressive the mixing. Thompson and Sun found larger offset angles of 
kneading elements resulted in higher torque during the granulation process and yielded 
dense and large granules. This is attributed to the increased shear and extensional stress 
as the material was squeezed through the openings between the discs and intermeshing 
region. However, the effect of the offset angle was found to be less significant as the 
degree of fill decreased (Thompson & Sun, 2010). The disc width strongly influenced the 
friability and density of granules, in which thicker discs lead to more compacted granules 
with higher tensile strength (Thompson & Sun, 2010; Van Melkebeke, B. et al., 2008). It 
was also found that, if conveying elements were added after the kneading elements, 
breakage and attrition of oversized granules will be observed, suggesting that the granule 
size can be controlled by modifying the conveying elements position post kneading block 
(Van Melkebeke, B. et al., 2008).  More intense mixing and higher granule temperature 
can negatively impact the stability of drug substance. Therefore, the screw configuration 




distribution and granule growth without being too aggressive to decrease the 
physicochemical stability of drug substance. 
2.6 BINDER DISTRIBUTION 
Improved tabletability of granules prepared using TSMG is attributed to the 
modification of the granule surface by highly compressible thermal binders. Therefore, 
binder distribution in the granules is critical to their tabletability (Steffens & Wagner, 
2019a).  
Binder distribution within the TSMG granules has been investigated using various 
techniques. Confocal Raman microscopy was applied to examine the binder distribution 
of imatinib mesylate-HPC granules. Each component showed different Raman spectra 
which were mapped and differentiated with different colors. The Raman mapping 
confirmed the crystalline state of imatinib mesylate and the thin layer of HPC distributed 
on the surface of drug crystals. This unique spatial distribution of drug and binder 
resulted in higher tabletability and lower friability (Vasanthavada, Wang, Haefele, 
Lakshman, Mone, Tong, Joshi, & AT, 2011). Near-infrared chemical imaging analysis 
was applied to visualize binder distribution in cross sections of caffeine-Soluplus® 
granules. The shear force during granulation led to the “squeeze-out” (enrichment) of 
Soluplus® onto the granule surface. The distribution of Soluplus® became more uniform 
under higher barrel temperature. (Monteyne, T., Heeze, Liza, et al., 2016). Scanning 
electron microscopy coupled with energy-dispersive X-ray was utilized to probe the 
binder distribution in dicalcium phosphate-poloxamer granules. Carbon mapping was 
used to visualize the distribution of poloxamer in the granules due to the absence of 
carbon atoms in dicalcium phosphate. The binder distribution study results showed a 
positive correlation between binder distribution uniformity and tabletability (Steffens & 
Wagner, 2019a). 
Time-of-flight secondary ion mass spectrometry (ToF-SIMS) was applied in our 
lab to construct the binder distribution map of gabapentin-HPC granules. With a shallow 




composition of granule  surfaces by detecting the time-of-flight of secondary ions 
generated from bombarding the granule surface with a primary ion pulse (Furudate et al., 
2015). Gabapentin (GABA) and HPC signal are differentiated based on the specific 
mass-to-charge ratio (m/z) of each component. As shown in Figure 2.6, an increase of 
HPC signal (C2H3O
-) and a decrease of GABA (CH2N
-) signal intensity indicate the 
enrichment of HPC on the surface of gabapentin granules. This surface modification 






Figure 2.6  (A) Binder distribution in gabapentin-HPC ELF granules samples at different 
zone of extruder analyzed byToF-SIMS. Blue color is indicative of HPC and red color is 
indicative of GABA. (B) The signal intensity of C2H3O
- and CH2N
- on the surface of 




2.7 CHALLENGES OF TSMG  
The major challenge of TSMG is undesired physicochemical changes of drug 
substance.  During TSMG, formulations are exposed to both elevated temperatures and 
high mechanical energy. Undesired changes include particle size reduction, polymeric 
transformation, chemical degradation, and amorphization.  All these changes are 
dependent on the processing conditions (screw speed, feed rate, and barrel temperature), 
screw configuration and drug-binder miscibility as shown in Figure 2.7.  
 
Figure 2.7  Schematic diagram demonstrating the major factors that contribute to the 
physicochemical instability during TSMG. 
2.7.1 Polymorphic transformation 
TSMG involves both thermal stress and mechanical stress generated from the 
barrel and frictional viscous dissipation during the process. The machine consists of 
variable configurations of screw elements which provides different mechanical stress 
profile. However, the shear stress is mainly generated by the kneading element 
(Andersen, 2018). During TSMG, the metastable form might be generated and remain 
stable inside the barrel via kinetic trapping and relaxation mechanism (Morris, Griesser, 
Eckhardt, & Stowell, 2001). Upon the existing of the extruder, the metastable form 
should thermodynamically relax to its stable form. However, depending on the cooling 
rate and the molecular interaction between drug and polymer, the metastable form might 




Polymorphic transformation of drug substance can lead to physicochemical 
stability changes. For example, the conversion of acetaminophen form I (monoclinic) to 
form II (orthorhombic) during TSMG has been reported, in which form II showed 
improved tabletability due to the sliding planes present in the orthorhombic form, causing 
fragmentation and plastic deformation under high compression pressure (Grymonpré et 
al., 2016; Maniruzzaman et al., 2014). The polymorphic transformation of Indomethacin 
was also found during TSMG with PEG 3350 as the binder. Indomethacin converted 
from the stable 𝛾 form to a mixture of the amorphous state and the metastable 𝛼 form, in 
which the amorphous will subsequently undergo the recrystallization back to the 
metastable 𝛼 form during the cooling. It was found that the thermal stress was the 
dominant factor that stimulates the polymorphic transition of indomethacin (Xu et al., 
2018). (Otsuka, Otsuka, & Kaneniwa, 1994).  
 Multiple variables during the process, including formulation and processing 
conditions, can significantly impact the extent of polymorphic transformation. The 
influence of binder on the polymorphic transformation has been observed by Monteyne et 
al. Conversion of caffeine anhydrous form II to I was detected during TSMG with 
Soluplus®. As the Soluplus® level was increased from 5% to 30%, the onset temperature 
of the polymorphic conversion shifted to a lower temperature (120 to 110°C). It was 
explained that the polymer acts as an impurity which absorbed on the surface of drug 
crystal. Polymer, therefore, can disturb the crystal arrangement at the molecular level, 
causing polymorphic transformation (Monteyne, Tinne et al., 2016; Tiwary, 2007). The 
conversion of gabapentin form II to form IV was found in TSMG of gabapentin-HPC 
based granules when using 60° trilobed kneading elements (Leistritz Nano-16). 60° 
trilobed kneading elements functions as neutral elements in which there is no conveying 
capacity to transfer the material forward. Such elements exhibit aggressive dispersive 
mixing. The material was imposed on intense thermal and mechanical stress, causing the 
conversion of polymorph to metastable form (form IV) which was more stable under the 




gabapentin was then trapped inside the granules following the process and highly 
susceptible to further chemical degradation (Kittikunakorn, N., Sun, C. C., et al., 2019). 
2.7.2 Chemical degradation 
Another challenge of TSMG is the potential chemical degradation of drug 
substance. The chemical instability of drug substance is attributed to various factors, 
including (1) melting of the drug and subsequent degradation, (2) solubilization of drug 
in molten binders, (3) amorphous form generated following the processes which is 
susceptible to degradation, and (4) crystal size reduction of drug substance. As previously 
discussed, thermal and mechanical stress during TSMG can induce the transition from the 
crystalline form to the metastable or amorphous form of the drug substance. Even though 
some drug molecules are not susceptible to polymorphic transformation, partially 
amorphization or disordered crystal lattices can occur under high mechanical stress. The 
amorphous or crystal defects exhibit high free energy which substantially accelerates 
chemical degradation due to the greater molecular mobility (Yoshioka & Aso, 2007).  
The interaction between drug and polymer is one of the factors that can promote 
amorphization upon elevated temperatures and high mechanical stress during TSMG. 
Drug molecules can fully or partially dissolve in the polymer melt if they are miscible 
and subsequently undergo chemical degradation (Alexis, 2005). For a drug with good 
chemical stability, such as metformin, the dissolution of the drug in polymer melt might 
be less concerning in terms of chemical stability. However, dissolved drug in polymer 
melt can potentially change the physical properties, such as compressibility, flowability 
or dissolution of granules (Hou et al., 2019). In addition, the recrystallization of dissolved 
drug can occur upon storage, leading to variation of the physical properties of granules. 
Therefore, to minimize the amorphization, thermal binders that are immiscible with drug 
would be preferred.  
Binder viscosity also impacts the chemical degradation during TSMG. Higher 
barrel temperature and higher mixing energy are required to soften or melt thermoplastic 




mechanical stresses as well, causing amorphization and particle size reduction. The effect 
of three thermal binders, including HPC, PEG 8000 and Compritol, on the 
physicochemical properties of gabapentin granules was evaluated in our study. Due to the 
high melt viscosity of HPC as compared to PEG8000 and Compritol, a significant size 
reduction of gabapentin in HPC-based formulation from 63 µm to 10 µm was observed 
which predominately occurred over the kneading block. The crystal defect of gabapentin 
was also observed by using scanning electron microscopy (SEM) showing the roughness 
of crystal surface. The generated crystal defect is normally a region that exhibits higher 
free energy and greater molecular mobility, which can serve as sites for initiation of 
chemical reactions (Newman & Zografi, 2014). Therefore, the higher crystal defects are 
generated, leading to the faster degradation kinetics in the granules (Kittikunakorn, Nada 
et al., 2019). 
Processing parameters, including feed rate and screw speed, also contribute to 
chemical degradation during TSMG as they can alter the residence time, degree of fill, 
and mechanical energy input to the material  (Kittikunakorn, N., Sun, C. C., et al., 2019). 
Increasing screw speed and decreasing feed rate generally increase the specific 
mechanical energy applied to the material. For amorphous solid dispersion by hot-melt 
extrusion (HME), there was a positive correlation between SME and degradation, as 
observed in formulations of meloxicam and copovidone  (Haser, Abbe, Huang, Siyuan, 
Listro, Tony, White, David, & Zhang, Feng, 2017a). However, the observed correlation 
between processing conditions and chemical degradation in TSMG differed depending on 
the extruder geometry. Degree of fill was found to positively correlate with chemical 
degradation of GABA granules processed in small extruders (Leistritz Nano-16) due to 
the high axial compaction force. Crystal size reduction was found in granules processed 
at high degree of fill which corresponds to higher chemical degradation due to an 
increase in the specific surface and crystal defect (Kittikunakorn, N., Sun, C. C., et al., 
2019). Granule formation in larger extruders (Leistritz Micro-18), on the other hand, was 
predominantly based on the mechanical energy generated at the kneading element as 




correlated with SME. The higher SME was, the more crystal defect or amorphization 
occurred, subsequently leading to more chemical degradation. 
Screw configuration also plays a critical role that contributes to the chemical 
degradation during TSMG. High compressive and shear forces are predominately 
generated at the kneading element which corresponds to particle size reduction and the 
high degradation level. However, narrow-pitch conveying element located prior to 
kneading element was also reported to introduce compressive force to the material as a 
result of an increased degree of fill in the screw channel (Kittikunakorn, Nada et al., 
2019). Therefore, to decrease the chemical degradation, screw design with the 
minimization of packing should be considered. This includes avoiding the use of highly 
aggressive kneading elements in the mixing zone and a long length of narrow-pitch 
conveying elements. Also, large-pitch conveying elements located after the mixing zone 
is preferred to minimize the thermal stress by efficiently transferring granules out of the 
extruder. 
2.8 PROCESS ANALYTICAL TECHNOLOGY (PAT) IN TWIN-SCREW MELT 
GRANULATION 
One of the main drives behind the pharmaceutical industry’s interest in TSMG is 
the benefits TSMG provides as a continuous process. Process data (also known as soft 
sensor), such as extrusion torque, barrel temperature, and barrel heating and cooling 
duration can be used for predicting granule quality. Several techniques have been 
recently developed and utilized for in-time monitoring of granule quality attributes such 
as granule size, granule temperature, flow properties, content uniformity, and solid-state 
properties (Fonteyne et al., 2012).  Various imaging techniques can be used to 
characterize size, shape, and surface roughness of granules prepared using TSMG. 
EyeconTM 3D Particle Characterizer was used to monitor TSMG granules (Kumar et al., 
2015b; Liu, H. et al., 2019). This technique is based on high-speed imaging using 
illumination pulses to capture the movement of the particles, providing surface 




applied in other granulation processes such as fluidized bed wet granulation (Burggraeve 
et al., 2010), high-shear wet granulation, and twin-screw wet granulation (Madarász et 
al., 2018). The process could be readily adapted in TSMG process. In spatial filter 
velocimetry, the size and velocity of the granules are measured as the particles pass 
through a laser beam and cast shadows onto a linear array of optical fibers. Photometric 
stereo imaging (FlashSizer FS3D) technique was used to simultaneously evaluate the 
granule size distribution, granule shape, and surface roughness. The granules are 
illuminated with light sources from different incident angles to create 3D surfaces with a 
photometric approach. The three-dimensional features of the surface images created are 
then used in particle size analysis. The surface roughness is evaluated based on the 
different intensity of the grey level in the images (Fonteyne et al., 2012). 
Raman spectroscopy and Near-Infrared Spectroscopy (NIR) are two PAT tools 
commonly used to determine the content uniformity (Fonteyne et al., 2016; Harting & 
Kleinebudde, 2018) and solid-state properties (Fonteyne et al., 2012). Raman 
spectroscopy measured the light scattered from a sample by using the laser light as an 
excitation source, while NIR measures the transmittance of electromagnetic radiation at 
the wavelength in the range of 780 to 2500 nm after interacted and absorbed by the 
sample. The fingerprint spectra obtained from both techniques reveal the chemical 
composition at the atomic scale and can be used to quantify the concentration and the 
solid-state properties of APIs. Raman and NIR spectroscopy for real-time process 
monitoring typically provided a huge number of spectra. Multivariate data analysis is 
applied to process and develop the model to interpret the data from the raw spectra 
(Otsuka, Mouri, & Matsuda, 2003). Infrared sensors can be used to measure granule 
temperature. 
2.9 CONCLUSION 
TSMG is a technique that has rapidly gained popularity recently as an alternative 
method for granulation. To transition from the traditional batch process to the continuous 




variables can affect the quality attributes of granules. Several studies have been 
conducted in an effort to provide a more mechanistic understanding and to show the 
potential for adoption and implementation of this technique. However, despite the several 
advantages offered by TSMG, because the process involves elevated temperatures and 
intensive high shear, the challenges related to physicochemical instability of drug 
substances still need to be considered and addressed. Several in-line monitoring 
techniques and PAT have to be employed due to the complexity of the system to 
visualize the active process. Moreover, modeling of the TSMG is another area that needs 
to be developed for process understanding, optimization, and scale-up. Ultimately, 
despite the challenges that need to be overcome, TSMG still remains an attractive 
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3 Chapter 3: Effects of Thermal Binders on Chemical Stabilities and 
Tabletability of Gabapentin Granules Prepared by Twin-Screw Melt 
Granulation2 
3.1 ABSTRACT 
The effect of thermal binders on the physicochemical properties of gabapentin, a 
thermally labile drug, in granules prepared using twin-screw melt granulation was 
investigated in this study. Hydroxypropyl cellulose (HPC), a thermoplastic high 
molecular-weight binder, was compared against conventional low molecular-weight 
semi-crystalline thermal binders PEG 8000 and Compritol. Both the chemical 
degradation and polymorph form change of gabapentin were analyzed. The effects of 
particle size and molecular weight of HPC on the properties of granules were also 
studied. To overcome the high melt viscosity of HPC, higher barrel temperatures and 
higher specific mechanical energy were required to attain suitable granules. As a result, 
higher levels of gabapentin degradant were observed in HPC-based formulations. 
However, gabapentin form change was not observed in all formulations. Smaller particle 
size and lower molecular weight of HPC led to faster granule growth. The tabletability of 
granules was insensitive to the variations in particle size and molecular weight of HPC. 
Gabapentin crystal size reduction, HPC size reduction, and HPC enrichment on granule 







2 Kittikunakorn, N., Koleng, J. J., Listro, T., Calvin Sun, C., & Zhang, F. (2019). Effects of 
thermal binders on chemical stabilities and tabletability of gabapentin granules prepared by twin-
screw melt granulation. International Journal of Pharmaceutics, 559, 37-47. 






The majority of marketed pharmaceutical tablets and capsules are manufactured 
using granulation processes, such as wet, melt, and dry granulation. Powders are 
granulated to prevent material segregation and to improve powder properties (e.g., 
flowability and tabletability) (Iveson, Simon M., Litster, Hapgood, & Ennis, 2001; 
Kittikunakorn, N., DiNunzio, Martin , & Zhang, 2018). All three granulation techniques 
are also used across many other industries, such as the food and plastics industries. Melt 
granulation offers several advantages over wet granulation and dry granulation, because it 
is solvent free and can effectively improve the tabletability of the granule (Batra, A. et 
al., 2017).  During melt granulation, the enlargement of granules is facilitated by molten 
thermal binders, which solidify upon cooling after exiting the granulator. Pharmaceutical 
melt granulation is traditionally carried out in batch-process equipment, such as high-
shear granulator equipped with heating jacket, and fluid-bed granulator. 
In pursuit of better process control and more consistent product quality, other 
industries, such as metallurgy and energetic materials gradually transitioned from batch 
to continuous melt granulation using twin-screw extruders in early 1970s (Dombe, 
Mehilal, Bhongale, Singh, & Bhattacharya, 2015). In contrast, the adoption of twin-screw 
melt granulation (TSMG) has been slow in the pharmaceutical industry.  However, with 
the introduction of twin-screw granulation technology (Gamlen, M. & Eardley, C., 1986) 
in 1986 and the first disclosed patent of  the twin-screw granulation (US patent 6,499,984 
B1) by the Warner-Lambert company, the TSMG technique has gained attention as an 
alternative method to wet and dry granulation (Ghebre-Sellassie, I. et al., 2002). Renewed 
interest in twin-screw melt granulation by both pharmaceutical companies and regulatory 
agencies are also driven by the increased interest in continuous manufacturing of 
pharmaceutical products (Lee, 2017). 
TSMG operates under different principles and offers many advantages over batch 
melt granulation. Even though the TSMG operates under globally starved conditions (the 
extruder barrel is 30 to 70 percent filled during processing), the processing section of a 




pressurized (fully filled in mixing elements) segments, dictated by the screw elements 
)White & Bumm, 2010(. In comparison, powder is always under the globally starved and 
is unpressurized conditions and randomly subjected to the high shear zone in a batch 
granulator, potentially resulting in non-uniform mixing dynamics. In TSMG, the material 
is forced through a sequence of starved and pressurized zones in accordance to the screw 
element design. As a result, granules prepared using TSMG have a more uniform mixing 
history, where incoming blend is processed in a principle of first-in, first-out with a given 
residence time distribution. This allows the system to operate in a state of control and to 
ensure the consistent quality of granules )Chen et al., 2016; White & Bumm, 2010(. 
Process analytical technology (PAT) could be implemented to monitor the properties of 
granules on line and in real time during TSMG. For example, Raman and near infrared 
spectroscopy have been applied to monitor drug content uniformity (Paudel, Raijada, & 
Rantanen, 2015). Acoustic emission is used to monitor the granule size distribution 
(Markarian, J., 2017). Granule monitoring technologies, such as the Eyecon® imaging 
system, were also used to assess granule size distribution (Kumar et al., 2015b). 
The TSMG process is more versatile and can process a wider range of powder 
compositions than batch melt granulation. During TSMG, powder blends are heated by 
not only the heat conducted from the barrel but also the viscous or frictional heat 
dissipation from the mixing by rotating screws, making it feasible to use high melting 
point (or softening-point) thermoplastic materials, such as hydroxypropyl cellulous 
(HPC), methacrylate copolymers, and copovidone (Batra, A. et al., 2017). 
TSMG has been applied to prepare a wide range of dosage forms, such as 
immediate release tablet (Lakshman et al., 2011b), modified release tablets 
(Vasanthavada, Wang, Haefele, Lakshman, Mone, Tong, Joshi, & Serajuddin, 2011), wax 
matrix granules (Keen et al., 2015), and water-dispersible granules (Van Melkebeke, 
Barbara et al., 2006). TSMG provided a robust manufacturing process with highest 
compactibility and lowest friability that were not sensitive to changes in atmospheric 




products by decreasing the need for relatively large amounts of excipients generally used 
to overcome physicochemical limitations of drug substances (Lakshman et al., 2011b). 
Vasanthavada and his colleagues demonstrated that the level of drug release retardant 
could be reduced with TSMG process. This unique advantage of TSMG for modified 
release tablets is particularly beneficial for high-dose drug (Vasanthavada, Wang, 
Haefele, Lakshman, Mone, Tong, Joshi, & Serajuddin, 2011). In Keen and Van 
Melkebeke’s studies, extrudates granules were used as the final dosage forms with 
desired drug release characteristics without further processing (Keen et al., 2015; Van 
Melkebeke, Barbara et al., 2006). Studies have been carried out to investigate the effect 
of thermal binder type (Batra, A. et al., 2017), thermal binder level (Lakshman et al., 
2011b), screw profile, and processing conditions on the properties of granules 
(Weatherley, S., Mu, Thompson, Sheskey, & O'Donnell, 2013). All these studies focused 
primarily on the flow and compaction properties of the granules. In general, the level of 
binders required to achieve desired compactability is low (5-20%) for TSMG 
formulations.  
The mechanisms of granule formation have also been studied (Monteyne, T., 
Heeze, L., Mortier, S. T., Oldorp, K., Cardinaels, R., et al., 2016). Spectroscopic analysis 
revealed drug–polymer interactions which constrain the polymer to flow independently. 
As a result, the binder distribution step, which generally follows the immersion step, was 
hindered. This insight assisted the understanding of the granule properties. 
Inhomogeneous granules were produced due to large initial nuclei or adhesion of multiple 
smaller nuclei. Consequently, a higher granulation temperature was required in order to 
get the binder more homogeneously distributed within the granules (Monteyne, T., 
Heeze, L., Mortier, S. T., Oldorp, K., Cardinaels, R., et al., 2016). Since powder blends 
are exposed to high thermal and mechanical stresses during TSMG, the chemical 
degradation and the polymorphic transformation of the drug substance is a potential 
challenge to successful manufacturing. However, the effects of formulation composition 
on the chemical and physical stabilities of drugs during TSMG have rarely been 




The main objective of this study was to investigate the effect of thermal binders 
on the stabilities (physical and chemical) and tabletability of melt-extruded granules. 
Gabapentin (GABA), a thermally labile drug, was used as the model compound. Three 
types of thermal binders were investigated: PEG 8000 (low-melting point hydrophilic 
binder), Compritol (low-melting point hydrophobic binder), and HPC (thermoplastic 
binder) (Figure 3.1).  As a high-dose drug (600 or 800 mg unit dose) with poor 
compaction properties, commercial GABA tablets are manufactured using high-shear or 
fluid-bed granulation process. GABA is thermally labile and undergoes an intra-
molecular cyclization dehydration reaction to yield gabapentin-lactam upon melting at 
174oC (Figure 3.2). The rate of GABA degradation is not only a function of temperature 
but also GABA crystallinity. Spray-dried amorphous solid dispersions of GABA in HPC 
at 10% and 20% drug loadings completely degraded within one week of storage in 
induction-sealed HDPE bottles placed at 40C/75% RH. In comparison, only less than 
0.1% crystalline GABA drug substance degraded under the same condition. GABA was 
also chosen because it undergoes polymorphic transition at elevated temperatures (Hsu, 









Figure 3.1  Chemical structures of (A) gabapentin (GABA), (B) polyethylene glycol 8000 
(PEG 8000), (C) glycerol behenate (Compritol), and (D) hydroxypropyl cellulose (HPC). 
The second objective was to investigate the effect of HPC variability on the 
physicochemical properties of TSMG GABA granules. HPC is available from Ashland 




effects of these physical attributes of HPC on GABA chemical stability and granule 
tabletability were investigated. The third objective was to study the spatial arrangement 
of HPC and GABA in the GABA TSMG granules. Time-of-flight secondary ion mass 
spectrometry was applied to determine the distribution of GABA and HPC on the surface 
of the granules.  
 
Figure 3.2  DSC and TGA thermograms of gabapentin (GABA) drug substance. At the 
melting point temperature of GABA, TGA thermogram shows the 10% weight loss due 
to chemical degradation. 
3.3 MATERIALS AND METHODS 
3.3.1 Materials 
Gabapentin was purchased from ShenZhen Nexconn Pharmatechs (Shenzhen, 
China). Hydroxy propyl cellulose (Klucel® ELF and Klucel® EXF) was kindly donated 
by Ashland Inc. (Wilmingotn, DE). Polyethylene glycol (PEG 8000) was obtained from 
Spectrum Chemical (New Brunswick, NJ). Glyceryl behenate (Compritol) was supplied 








































3.3.2.1  Twin-screw melt granulation 
A physical mixture consisting of 80% (w/w) GABA and 20% (w/w) binder was 
prepared in a Turbula® Shaker-Mixer (Glen Mills, Clifton, NJ) for ten minutes. All 
granulation experiments were performed on a Leistritz Nano-16 co-rotating twin-screw 
extruder (American Leistritz Extruder Corp., Somerville, New Jersey) with an open-end 
discharge configuration. A 12 mm twin-screw volumetric feeder (Model MT-1, 
Brabender Technologies, Ontario, Canada) was used to meter the powder blend into the 
extruder. Screw configuration, processing parameters, and extrusion torque are 
summarized in Table 3.1. The feeding zone was cooled with water. Zones 1 and 2 were 
set at equal temperatures. Zone 3 was set at a lower temperature to allow the granules to 
cool down prior to exiting the barrel and before cooling at ambient conditions. 
Table 3.1  Summary of process setup and extrusion torque for twin-screw melt 
granulation. 
Formulation 







(Nm) Zone 1 Zone 2 Zone 3 
80%GABA+20%Compritol 80 80 40 10 100 0.7-1.0 
80%GABA+20%PEG 8000 90 90 60 10 100 1.8-2.0 
80%GABA+20%HPC 120 120 70 10 100 5.0-5.2 
 
 
GFA X-XX-XX Co-rotating conveying screw-trilobal screw-pitch length (mm)-screw length (mm)    
KB X-X-XX-XX Kneading block-number of kneading segment-screw length (mm)-the angle () 




3.3.2.2  Miscibility of Gabapentin with thermal binders  
Gabapentin-binder miscibility was analyzed using differential scanning 
calorimetry and hot-stage polarized light microscopy. A differential scanning calorimeter 
(DSC Q20, TA Instruments, New Castle, DE, USA) was used to determine the 
depression of GABA’s melting point in drug-binder mixtures. Mixtures with GABA 
content ranging from 10 to 80% were prepared using mortar and pestle. About 5 mg of 
mixture was sealed in a hermetic aluminum pan with a pin hole pierced through the lid. 
Samples were heated at 5 C/min to the respective Zone 2 processing temperature during 
TSMG for each binder and held for 5 minutes prior to heating to 250C at 20C/minute.  
The physical mixtures consisting of 80% GABA and 20% of different binders 
were heated on a hot-stage placed under a polarized light microscope (BX-53, Olympus, 
Waltham, MA) to the respective Zone 2 processing temperature of TSMG. The changes 
in the size and shape of GABA crystals were monitored in real-time. Images were taken 
with a QICAM digital camera (QImaging, BC, Canada) with Q capture software (Ver. 
2.0.13, QImaging, BC, Canada). 
3.3.2.3  Granule size distribution 
Granule size distribution was characterized using Retch Camsizer® Dynamic 
Image Analyzer apparatus (V.4.2.1., Haan, Germany). Approximately 10 g of granules 
were poured into the feeder of the instrument. The granules were then dropped in front of 
the measuring cameras to record the particle size with an image rate of 100% (1:1) and a 
display interval of 50. The covered area of the image recorded by CCD-Basic and CCD-
Zoom, which was included in the measurement, was set at 2%. The measured particle 
size range was between 53 µm - 4000 µm. The control level for fast forward and the 
starting level for measurement of the feeder were set at 65 and 55, respectively.   
3.3.2.4  Image analysis using scanning electron microscope 
The morphology of GABA crystals and granules was analyzed using a scanning 
electron microscope (SEM, Zeiss Supra40, USA). Prior to imaging, samples were 




platinum/palladium to achieve 12 nm thickness. Samples were analyzed under vacuum 
with the electron beam operating at 5 kv. 
Melt-extruded GABA granules were initially dispersed in solvents that do not 
dissolve GABA but easily dissolve thermal binders. Acetone was used for GABA-PEG 
8000 and GABA-HPC granules, while chloroform was used for GABA-Compritol 
granules. The dispersions were stirred with magnetic stirrer for at least 2 hours to 
dissolve thermal binders. Dispersed GABA crystals were collected using centrifugation 
method. The crystals were dried at ambient conditions prior to SEM analysis. 
3.3.2.5  Tabletability of melt-extruded granules 
Granules prepared using TSMG were milled using a conical mill (Quadro Comil, 
U5-0516, Ontario, Canada). A 0.032-inch, round-hole screen and a square impeller at 
1000 rpm were used for all formulations. Granules between 250 µm to 850 µm (20 to 60 
mesh) were collected and mixed with 1% magnesium stearate for 3 minutes in a 
Turbula® Shaker-Mixer (Glen Mills, Clifton, NJ). Tablets (350±5 mg) were compressed 
with a manual tablet compression machine (MTCM-I, Globe pharma, NJ, USA) using 11 
mm flat-faced round tooling. Tablet diametrical breaking strength, thickness and diameter 
(n=5) were recorded and the tensile strength (MPa) of the tablets was calculated using 




 Equation 3.1 
where F, D and H denote the tablet breaking force (N), tablet diameter (mm) and tablet 
thickness (mm), respectively.  
3.3.2.6  HPLC analysis of gabapentin and gabapentin-lactam of granules 
GABA and GABA-latam content of the granules was analyzed with a Thermo 
Scientific Dionex UltiMate 3000 HPLC System (Thermo Scientific, Sunnyvale, CA, 
USA). Chromeleon software (Version 6.80, Thermo Scientific, Sunnyvale, CA, USA) 
was used to process all chromatography data. An Inertsil® ODS-2, C18 reverse phase 
HPLC column (4.6 x 150 mm, with 5-µm packing, GL Sciences Inc., Japan) was used. 




isocratic flow at 0.8 mL/min was used. The analysis wavelength was 210 nm. The 
retention time of GABA and GABA-lactam was approximately 32 and 12.8 min, 
respectively. Purified water was used as the extraction medium. The nominal 
concentration of GABA was 5 mg/mL.  Samples were sonicated and filtered through a 
0.45 µm Nylon membrane prior to HPLC analysis. The injection volume was 20 L. The 
LOD and LOQ of GABA-lactam were 0.03 and 0.08 𝜇g/mL, respectively. 
3.3.2.7  Melt viscosity of thermal binders 
The melt viscosity of the binders was determined using a melt rheometer 
(AR2000, TA Instruments, New Castle, DE, USA) with a 25 mm ETC steel plate. The 
viscosity of PEG 8000, Compritol ATO888, and HPC ELF was measured at temperatures 
of 80, 90, and 120C (corresponding to extrusion barrel Zone 2 temperatures), 
respectively, with the shear rate ranging from 100 to 1000 s-1. Normal force was between 
10 and 15 N. The sample was equilibrated at the target temperature for 3 min before each 
measurement.  
3.3.2.8  FT-IR analysis 
FT-IR analysis was performed to determine the polymorphic form of GABA in 
the physical mixture and granules using a Thermo Nicolet iS50 spectrometer 
(ThermoFisher Scientific, Waltham, MA) equipped with an attenuated total reflection 
accessory. Sample was placed on the germanium crystal surface, compressed using the 
built-in pressure tower to achieve uniform contact between the solid and the crystal. The 
samples were analyzed at room temperature with the following setting: 4000−600 cm−1, 
64 scans, resolution of 4 cm−1. The peak positions were determined using OMNIC 
software peak picking function (ThermoFisher Scientific, Waltham, MA). 
3.3.2.9  Particle size of gabapentin in melt-extruded granules 
The particle size of GABA in the TSMG granules was determined using a laser 
diffraction method. The granules were first dispersed in a solvent that practically does not 




dispersions. The dispersions were stirred with magnetic stirrer for at least 2 hours to 
dissolve thermal binders. Acetone was used for GABA-PEG 8000 and GABA-HPC 
granules, while chloroform was used for GABA-Compritol granules. The size of the 
resulting dispersed GABA crystals was measured using a laser diffraction size analyzer 
(Sympatec Helos equipped with an R3 lens and a cuvette dispersing system, Sympatec 
GmbH, Germany).  The corresponding solvent (acetone or chloroform) was used as a 
blank solution in the cuvette and stirred with magnetic stir bar to prevent the 
sedimentation of GABA during analysis. Concentrated GABA dispersions were added 
drop-wise until the light obscuration reached 10-25%.  Data was then collected every 
100 ms for 10 seconds. 
3.3.2.10  Time-of-flight secondary ion mass spectrometry (ToF-SIMS) 
The distribution of GABA and binder on the surface of the granules was 
determined using Time-of-flight secondary ion mass spectrometry (ToF-SIMS) (ION-
TOF GmbH, Germany). A sample was placed on carbon tape fixed to the sample plate. 
The operating conditions consisted of a 30 keV Bi3+ analysis beam and a 500 eV Cs 
sputter beam. The sample was sputtered with Cs for 400 sec prior to collecting the data. 
A 500 x 500 µm area of each sample was raster scanned at a resolution of 256 x 256 
pixels. Specific ion peaks for each component were determined. GABA and HPC were 
identified using the spectrum of CH2N
- (m/z = 28) and C2H3O
- (m/z = 43) peaks, 
respectively.  The measured intensity of the CH2N
- and C2H3O
- peaks was represented by 
brightness in the images. Binder distribution map was constructed by overlaying the 
intensity map of CH2N
- (representing GABA) and C2H3O
- (representing HPC). 
3.4 RESULTS AND DISCUSSION 
3.4.1 Selection of thermal binders and processing parameters 
Because of the challenges posed by high-dose, poor tabletability, and thermal 
instability of GABA, formulation composition and TSMG process must be designed to 




stability. Thermal binders were selected based on two criteria: (1) low melting point for 
semi-crystalline materials or glass transition temperature for amorphous binders, and (2) 
poor miscibility with GABA. These types of thermal binders would allow the processing 
at lower temperatures and lower mechanical stress, which correspond to lower tendency 
of physical and chemical changes in GABA.   
Amorphization of GABA from mechanical milling substantially accelerated 
GABA degradation (Zong, Z. X. et al., 2011). We have observed that spray-dried GABA 
dispersion consisting of 60% HPC and 40% GABA completely degraded following 2 
weeks storage at 40 C/75%RH. It is reasonable to expect that GABA dissolved in binder 
during TSMG that does not crystallize also degrades at a faster rate than crystalline 
GABA. Thus, our goal is to minimize the amorphization and crystal defects of GABA 
during TSMG. We hypothesize that good miscibility between GABA and thermal binders 
leads to poor chemical stability of GABA. Although this effect is of practical importance, 
the effect of drug-binder miscibility during TSMG on the chemical stability of drug has 
not been reported. Depending on the solubility of drug in molten binder, formulation 
blends for TSMG have been classified into miscible and immiscible systems (Monteyne, 
T., Heeze, L., Mortier, S. T., Oldorp, K., Cardinaels, R., et al., 2016). It has been 
demonstrated that the miscibility between drugs and thermal binders significantly affects 
the extrusion conditions (e.g., torque) and granule properties (e.g., size distribution and 
friability).  
All three thermal binders, PEG 8000, Compritol, and HPC, are free-flowing 
powders at ambient conditions but melt or soften at elevated temperatures during TSMG.  
Both PEG 8000 and Compritol are commonly used semi-crystalline binders in TSMG 
with melting points of 60 and 73C, respectively (Mu & Thompson, 2012; Tan, D. C. T. 
et al., 2014).  PEG 8000 is water-soluble while Compritol is water-insoluble. In 
comparison, HPC is a thermoplastic polymer with a glass transition temperature of about 
20C (Rials & Glasser, 1988).  Because of the high melt viscosity of HPC, powder blends 
containing HPC as a thermal binder can only be granulated by a twin-screw extruder and 




manufacture metformin granules in Eucreas™ commercial tablets (Lakshman et al., 
2011b). HPC is available in a wide range of molecular weights (40,000 – 1,150,000) and 
two particle sizes (regular grind with 250 m mean particle size and fine grind with 
50 m mean particle size). The HPC ELF, a low molecular weight (40,000) and a regular 
grind grade, was used in the current study. The effects of excipient variability were also 
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Figure 3.3  DSC thermograms of physical mixtures containing gabapentin (GABA) and 
binders (10, 20, or 80%); ramp from 25C to zone 2 processing temperature; hold at the 
processing temperature for 5 minutes; ramp further to 250C; (A) GABA-PEG 8000 with 
a zone 2 processing temperature of 80C; (B) GABA-Compritol with a zone 2 processing 
temperature of 100C; (C) GABA-HPC ELF with a zone 2 processing temperature of 
140C. 
TSMG was carried out at the Zone 2 barrel temperatures of 80, 90, and 120C for 




and Compritol, the barrel temperature was set at about 20C above the melting points of 
the thermal binders to ensure their complete melting. For HPC ELF, the barrel 
temperature was set at 100C above the glass transition temperature to ensure sufficient 
agglomeration.   
Drug-polymer interaction during TSMG is identical to that during hot-melt 
extrusion (HME) for amorphous solid dispersion. The primary goals of hot-melt 
extrusion are to dissolve drug in a polymer melt and to keep drug in the amorphous state 
after extrusion to improve drug dissolution. In contrast, the primary goal of TSMG is 
particle agglomeration, where drug dissolution in polymer melt should be minimized 
during TSMG to avoid gross physical and chemical instability, as mentioned for GABA.  
Miscibility and dissolution of drug in melt binder can be quantified using melting 
point depression analysis via DSC. Melting point depression results from the reduced 
thermodynamic activity of the drug in the presence of the excipients relative to the 
activity of the pure crystalline drug. Hence, the drug in the amorphous drug-polymer 
mixture has a chemical potential equal to that of the crystalline drug at a temperature 
lower than the melting temperature of the pure drug (Marsac, Li, & Taylor, 2009). The 
greater the extent of melting point depression, the greater GABA solubility in molten 
binder. No significant melting point depression of GABA was observed with any binder 
upon temperature ramping at 10oC/min (data not shown). Additional DSC analysis was 
performed by holding the drug-binder binary mixtures at the barrel temperature (Zones 1 
and 2) for 5 minutes to allow more time for GABA dissolution, if any. However, no 
thermal event was observed during this holding time and still no (PEG and HPC) or only 
slight (Compritol) melting point depression was observed in the subsequent temperature 
ramping beyond the melting temperature of GABA (Figure 3.3). Thus, GABA is 
immiscible with all three thermal binders. 
Hot-stage polarized light microscopic experiments, performed by heating and 
holding the drug-binder binary mixtures at elevated temperatures, also did not show any 
sign of GABA crystal dissolution, since GABA crystal did not undergo visible changes in 










Figure 3.4  Hot-stage polarized light microscope of physical mixture (A) 80% GABA-
20% PEG 8000, (B) 80% GABA-20% Compritol, and (C) 80% GABA-20% HPC ELF. 
3.4.2 Effect of thermal binders on the properties of melt-extruded GABA granules 
The effects of thermal binder on the tabletability of granules, crystal form, and 
crystallinity of GABA, and the chemical stability of GABA using different process 
parameters (Table 3.1) are discussed in the following sections.  
3.4.2.1  Tabletability of melt-extruded granules 
The size and shape of the TSMG GABA granules were highly dependent on the 
type of thermal binder (Figure 3.5). Compritol-based granules were the smallest with 
most granules smaller than 425 µm. GABA-PEG 8000 granules were ribbon-like. 
GABA-HPC granules were spherical with a size range of 100 µm to 2 mm. The size and 
shape of extrudates are affected by both the screw configuration and processing 
conditions. Following the granulation as the result of dispersive mixing in the kneading 




narrow-pitch conveying element and the extrudates were granular. In comparison, the 
ribbon-shaped extrudate was observed for GABA-PEG 8000 formulation. It was 
hypothesized that GABA-PEG 8000 granules did not fully solidify in the conveying 














Figure 3.5  Photo images (top row) of extrudate and scanning electron microscope images 
(bottom row) of milled granules containing 80% GABA and 20% of various binders. (A) 
PEG 8000, (B) Compritol, and (C) HPC ELF. 
Tabletability, tablet tensile strength as a function of compaction pressure, for 
milled and lubricated granules is presented in Figure 3.6. HPC ELF is the most effective 
in improving the tabletability of GABA. The desired tensile strength of 2.0 MPa (Osei-
Yeboah, F. & Sun, C. C., 2015b), is attained over the entire pressure range investigated 
(35–125 MPa). In contrast, tablets containing Compritol-based granules never reached 
2.0 MPa, while the tabletability of GABA-PEG 8000 granules was in between. The 
superior tabletability of HPC-based granules over that of PEG 8000 and Compritol-based 





Figure 3.6  Compression profiles of blends containing 99% melt-extruded granules or 
physical mixture and 1% magnesium stearate; 11 mm in diameter, round, flat-faced 
tooling; 350 mg in tablet weight. 
The tabletability of TSMG granules containing 20% HPC was much improved 
over the corresponding physical mixture (Figure 3.6). This could be attributed to the 
unique spatial distribution of HPC ELF in the granules, where GABA crystals were 
surface coated by HPC as discussed in a later section.  Such polymer coating is extremely 
effective in improving powder tabletability (Osei-Yeboah, F. & Sun, C. C., 2015a).   
3.4.2.2  Crystal form and crystallinity of GABA following TSMG 
In all four of its known crystal forms, GABA is zwitterionic and forms extensive 
networks of hydrogen bonds between -NH3
+ and -COO- groups of neighboring 
molecules. Form I is a monohydrate, and the other three forms are anhydrous. GABA 
Form II, the most stable anhydrous form, is used in the current study.  
Crystal form conversion of drug and excipient induced by thermal and mechanical 
stresses during TSMG has been reported (Liu, Y., Thompson, & O'Donnell, 2018). The 
potential changes of GABA crystal form were investigated using an FT-IR and XRD 
techniques, where polymorphic changes can be revealed by the emergence of new peaks, 
a shift in the position of the existing peaks, or a change in the shape of peaks in FTIR 




techniques. Only FTIR data is discussed here. The spectral region from 1700 to 1500 cm-
1 is indicative of GABA polymorphs, where the peak at 1615 cm-1 is the characteristic 
band of C=O stretching vibration of the ionized carboxylic group and the peak at 1546 
cm-1 is from N-H scissoring vibration of NH3
+ group. Compared to Form II, the C=O 
peak in forms III and IV shifts to a higher wave number, the N-H peak shifts to a lower 
wave number, and a new strong peak becomes present in the middle. IR band in the 
1500-1300 cm-1 region can be attributed to the asymmetric carboxylate band or CH2 
deformation band (Hsu, C. H. et al., 2010).  No significant change in the characteristic 
peaks of GABA Form II at 1615, 1546, 1475, 1420, 1400 and 1300 cm-1 was observed 
for all TSMG granules prepared in this work (Figure 3.7).  Thus, GABA form II 
remained stable during TSMG. The same observation was made for PEG 8000 and 
Compritol-based granules (data not presented).  
 
Figure 3.7 FTIR spectra of physical blends and melt-extruded GABA granules. PM: 
physical mixture, ME: melt-extruded granule. 
It was reported that amorphization of GABA resulting from mechanical milling 




amorphous GABA content was not detected in the granules using DSC and XRD because 
GABA is a fast crystallizer.  In fact, amorphous GABA could not be prepared by spray 
drying. Melt quenching methods also did not work because of the significant degradation 
of GABA upon melting. Of course, these methods may not be sufficiently sensitive to 
detect a small amount of amorphous content in a crystalline sample. Although GABA 
chemical stability data indicated the presence of lattice defects or amorphous GABA in 
the melt-extruded granules, they were at a level too low to be detected by these analytical 
tools.  
3.4.2.3  Chemical stability of GABA granules 
During milling using a planetary mill, a longer milling duration corresponded to a 
higher level of GABA-Lactam post milling and faster degradation during storage (Zong, 
Z. X. et al., 2011). Chemical degradation of GABA under an elevated temperature was 
also reported (Hsu, C. H. et al., 2010). Since GABA was exposed to both elevated 
thermal and mechanical stresses during TSMG, the chemical stability of GABA during 
TSMG and the storage was monitored in this study. 
 
Figure 3.8  Gabapentin-lactam profile of melt-extruded granules packaged with desiccant 
in induction-sealed HDPE bottle stored at 40°C/75% RH condition for 3 months. GABA 




Gabapentin-lactam (GABA-L) level after TSMG and at different time points 
under stressed conditions is presented in Figure 3.8. For storage stability testing, 1 g 
melt-extruded granules were packaged with 1 g desiccant in induction-sealed 20 cc 
HDPE bottles stored at 40 C/75% RH for 3 months. As-received GABA drug substance 
contained 0.02% GABA-L. For PEG 8000 and Compritol-based granules, the level of 
GABA-L after TSMG or during the 3 months storage did not increase. In contrast, 
GABA-L level elevated to 0.14% for HPC ELF-based granules immediately following 
TSMG and then increased linearly to 0.38% over 3 months storage. 
The poorer chemical stability of HPC ELF-based granules was likely attributed to 
both higher thermal and mechanical stresses during TSMG. Thermal stress during melt 
granulation originated from the heat conducted from extruder barrel. Mechanical stress 
resulted from the mixing by co-rotating screws. Mechanical stress also translated to 
thermal stress via frictional and viscous heat dissipation. Due to the high viscosity of 
binder melt, HPC ELF-based formulation had to be processed under a higher barrel 
temperature in order to achieve sufficient powder agglomeration, which corresponded to 
a higher level of thermal stress to GABA. The specific mechanical energy (SME) is the 
amount of power generated by the motor which is input into the material. SME can be 
calculated using Equation 3.2: 
𝑆𝑀𝐸 =
𝐾𝑊 (𝑚𝑜𝑡𝑜𝑟 𝑟𝑎𝑡𝑖𝑛𝑔) × % 𝑇𝑜𝑟𝑞𝑢𝑒 ×
𝑅𝑃𝑀 𝑟𝑢𝑛𝑛𝑖𝑛𝑔
𝑅𝑃𝑀 𝑚𝑎𝑥





 Equation 3.2 
Under the current processing conditions, SME for HPC ELF-based formulation 
(3.78 kW/kg/hr) was 3-6 times of that for PEG 8000 (1.78 kW/kg/hr) or Compritol (0.62 
kW/kg/hr)-based formulations. Thus, the mechanical stress to GABA is correspondingly 
higher in the HPC ELF-based granules, which is attributed to the higher melt viscosity of 
HPC than PEG 8000 and Compritol at their respective processing barrel temperatures 
(Figure 3.9). The peak shear and minimum channel shear rate in the current study were 
calculated to be 1674 and 70 sec-1, respectively by using equation 3.3:  
𝑆ℎ𝑒𝑎𝑟 𝑟𝑎𝑡𝑒 =
𝜋 𝑥 𝑆𝑐𝑟𝑒𝑤 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 𝑥 𝑠𝑐𝑟𝑒𝑤 𝑠𝑝𝑒𝑒𝑑 (𝑟𝑝𝑚)
𝑂𝑣𝑒𝑟𝑓𝑙𝑖𝑔ℎ𝑡 𝑔𝑎𝑝 𝑥 60





Figure 3.9  Melt viscosity of binders as a function of shear rate at their respective zone 2 
processing temperatures of three thermal binders. 
In this shear rate region, melt viscosity of HPC ELF is much greater than that of PEG 
8000 and Compritol. Both PEG 8000 and Compritol are Newtonian fluids with constant viscosity 
(about 0.02 and 1 Pa.s for PEG 8000 and Compritol, respectively) across the entire range of 
shear rate. In contrast, melt viscosity of HPC ELF decreased with increasing shear rate (from 100 
Pa.s to 20 Pa.s when the shear rate increased from 100 to 1000 sec-1).  
 
Figure 3.10  Gabapentin-lactam profile of melt-extruded GABA granules processed at 90°C, 





Figure 3.11  Particle size distribution of gabapentin (GABA) drug substance and GABA in melt-
extruded granules (average of triplicate analyses). 
 
(A) (B) (C) (D) 
    
    
Figure 3.12  Scanning electron microscope images (top row) and polarized light microscope 
images (bottom row) of GABA crystals in melt-extruded GABA granules (A) GABA drug 





To further investigate the effect of binder melt viscosity, TSMG for all three formulations 
was carried out at the same barrel temperature so that the amount of heat conducted from the 
barrel was similar. In such case, the impurity level was higher for HPC ELF-based granules 
across all temperatures (Figure 3.10).  The differences may be attributed largely to the different 
mechanical stresses in these cases.  The higher mechanical stresses during HPC ELF-based 
process were also demonstrated by the more significant size reduction and surface defect of 
GABA crystals in the GABA-HPC ELF granules.  D50 of the as-received GABA (63.1 m) was 
reduced to 42.9, 21.4 and 10.5 m in PEG, Compritol, and HPC-based granules, respectively 
(Figure 3.11). This is corroborated by SEM and polarized light microscopy analyses of GABA 
crystals extracted from granules (Figure 3.12), which show both smaller GABA particles and 
more visible defects. GABA crystals in PEG and Compritol-based granules exhibited smooth 
surfaces and sharp edges, while fragmentation and rough surfaces were observed with GABA 
crystals from HPC ELF-based granules.  
 
Figure 3.13  Gabapentin-lactam content of melt-extruded 80% GABA-20% HPC ELF granules 
packaged in open containers stored at 40C and various relative humidity conditions. 
The role of crystal defects on degradation of GABA in GABA-HPC ELF granules was 
also probed by comparing degradation kinetics at different humidity in open container, where 




available water at a higher humidity can facilitate faster recrystallization of amorphous GABA, 
or healing of crystal defects. Similar effects of RH on chemical stability was observed with ball 
milled GABA (Zong, Z. X. et al., 2011).   
3.4.3 Effect of excipient variability on the properties of HPC-based GABA granules 
Granulation consists of three processes: (1) wetting and nucleation, (2) consolidation and 
growth, and (3) attrition and breakage. All these three processes are impacted by the molecular 
weight and particle size of thermal binder. It is therefore important to understand the effects of 
excipient variability on the properties of HPC-based GABA granules.  
 
Figure 3.14  Size distribution of melt-extruded GABA granules based on different grades of 
HPC. Camsizer® was used in this analysis. ELF (40,000, 160 µm D50); EXF (80,000, 50 µm 
D50), and spray-dried EXF (80,000, 10 µm D50). 
HPC is available from Ashland chemical in a variety of grades with different molecular 
weights (40,000 – 1,150,000) and mean particle sizes (250 m for the regular grind grade and 50 
m for the fine grind grade). Three different grades of HPC, EXF (80,000 MW, 50 µm D50), 
spray-dried EXF (prepared in our lab, 80,000 MW, 10 µm D50), and ELF (40,000 MW, 160 µm 




HPC EXF and spray-dried EXF were used to study the effect of HPC particle size. The 
use of spray-dried HPC EXF led to larger extruded granules, with D50 and D90 increased from 
547 and 1049 µm to 825 and 1336 µm, respectively (Figure 3.14). During TSMG, “molten or 
softened” HPC must wet and spread on to the surface of GABA crystals to induce nucleation and 
growth of granules. With the compression arising from the axial pressure, the consolidation and 
growth mainly took place in the kneading segment. The intensive dispersive and distributive 
mixing in the kneading segment created progressively stronger granules, that steadily became 
more resistant to any further deformation-attempting consolidation (Iveson, S. M., Litster, & 
Ennis, 1996). Spray-dried HPC EXF provided higher specific surface area for wetting and 
nucleation, which also enhanced “consolidation and growth” to made granules sufficiently 
stronger to resist “attrition and breakage”. As a result, the melt-extruded granules were larger 
with HPC of finer particle size. 
It was also observed that melt-extruded GABA granules were larger with lower molecular 
weight HPC. Thermal binder molecular weight affects all three processes of granulation. 
Molecular weight has two opposing effects on the size of the granules. On one hand, lower 
molecular weight binder has a lower melt viscosity and is easier to spread onto the surface of 
GABA crystals, which leads to more efficient “wetting and nucleation” and “consolidation and 
growth” processes. On the other hand, lower molecular weight binder leads to weaker particle-
particle bridges, and thus higher extent of “attrition and breakage” during granulation and more 
friable granules. Consequently, granule size can be either larger or smaller when lower molecular 
weight binder is used. The overall impact of polymer molecular weight depends on which one of 
these two counteracting effects is more dominant. For examples, higher molecular weight of 
hypromellose led to larger granules (Liu, Y., Thompson, & O'Donnell, 2018), while the opposite 
effect by polyethylene glycol molecular weight was observed (Mu & Thompson, 2012). In our 
study, larger granules were obtained when lower molecular weight HPC was used, indicating the 









Figure 3.15  Compression profiles of A) physical mixtures and B) melt-extruded granules based 
on HPC of different molecular weight and particle size. ELF (40,000, 160 µm D50); EXF 
(80,000, 50 µm D50), and spray-dried EXF (80,000, 10 µm D50). 
While tabletability of the three physical mixtures differed (Figure 3.15A), there was no 
significant difference in the tabletability of GABA granules based on three different HPC grades 
(Figure 3.15B).  Thus, in term of granule tabletability, the TSMG process is robust against 





Figure 3.16  Gabapentin-lactam content of GABA drug substance and melt-extruded 80% 
GABA-20% HPC granules containing HPC of different particle sizes; processing conditions: 10 
g/min feed rate, 100 rpm screw speed and four different barrel temperatures (90, 100, 110 and 
120C). 
GABA granules with different HPC grades processed at different barrel temperatures (90-
120C, with the feed rate of 10 g/min, 100 rpm) were also examined for effects of processing 
temperature on chemical instability of GABA (Figure 3.16).  When the barrel temperature was at 
120 C, GABA-lactam level in spray-dried HPC EXF-GABA, HPC EXF-GABA, and HPC ELF-
GABA granules was 0.26, 0.23 and 0.11%, respectively. D50 of GABA crystals in TSMG 
granules was around 8-10 µm for all three granules. There was no discernable difference among 
these granules when subjected to XRPD, DSC and FT-IR analyses. The higher degradation in 
HPC EXF based granules may be attributed to the higher melt viscosity of HPC EXF during 
TSMG. As a result, GABA was exposed to a higher shear stress during the granulation, resulting 










Figure 3.17  (A) ToF-SIMS image (500 µm x 500 µm) of GABA-HPC ELF granules sampled at 
different processing zone. Blue color is indicative of HPC and red color is indicative of GABA. 
(B) the signal intensity of CH2N
- and C2H3O
- of HPC EXF and GABA at different processing 
zones. 
The improved tabletability of HPC EXF-based GABA granules was likely attributable to 
the coating of GABA surfaces by HPC as a result of the TSMG process. Surface modifications 
using highly bonding polymers have been shown to be highly effective in improving the 
compaction properties of powders (Shi, L. & Sun, C. C., 2010).  Time-of-flight Secondary Ion 
Mass Spectrometry (ToF-SIMS) imaging of granules recovered in different processing sections 




these granules.  The HPC in the granules was significantly smaller and more uniformly 
distributed than that in physical mixture. In addition, the signal intensity for HPC EXF increased 
as powder blend proceeds further along the barrel (Figure 3.17B), indicating surface enrichment 
of HPC EXF with the progression of the granulation process. Both the HPC EXF size reduction 
and surface enrichment are consistent with the surface coating mechanism used to explain the 
improved tabletability of the various HPC-GABA granules (Figure 3.15).  
3.5 CONCLUSION 
We have evaluated the effect of three types of thermal binders, PEG 8000, Compritol, 
and HPC ELF on the chemical stability and tabletability of GABA granules (80% drug loading) 
prepared using a twin-screw melt granulation process. Polymorphic form change of GABA was 
not observed under the current processing conditions for all three formulations. HPC ELF was 
found to be the most effective binder in improving the tabletability of GABA. Improvement in 
the tabletability resulted from the size reduction and surface-enrichment of HPC ELF in the melt-
extruded granules. 
However, HPC ELF also led to greater levels of GABA chemical degradation and 
significant size reduction of GABA crystals due to higher thermal and mechanical stresses. The 
impurity level in HPC ELF-based granules continued to increase from 0.14 to 0.38% upon 
storage for 3 months at 40 C/75% RH. For HPC ELF-based formulation, D50 of GABA crystals 
decreased from 63 to 10 m during TSMG. Higher thermal stress for HPC-based formulation 
resulted from (1) the higher barrel temperature required to achieve sufficient agglomeration and 
(2) greater heat dissipation due to the higher mechanical stress resulting from the higher melt 
viscosity of HPC ELF. Even though PEG 8000 and Compritol were not as effective as HPC ELF 
in improving the compaction properties of GABA, chemical degradation of GABA was not 
observed with PEG 8000 and Compritol-based granules. The impurity content of these granules 
did not increase following 3 months storage at 40 C/75% RH. Moreover, the granule properties 
were affected by the molecular weight and particle size of HPC. Lower molecular weight HPC 
corresponds to more efficient granulation and lower level of GABA degradation. Granule growth 
was also enhanced when HPC of smaller particle size was used.  Importantly, the tabletability of 
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4 Chapter 4: Effect of Screw Profile and Processing Conditions on 
Physical Transformation and Chemical Degradation of Gabapentin during 
Twin-Screw Melt Granulation3 
4.1 ABSTRACT  
Twin-screw melt granulation (TSMG) was applied to process a powder blend consisting 
of 80% gabapentin (GABA) and 20% hydroxypropyl cellulose. The effect of screw profile and 
processing conditions on the process-induced transformation and chemical degradation of 
gabapentin was studied. When a neutral kneading block was used, gabapentin underwent 
polymorphic transformation. A forward kneading block in combination with processing under 
torque conditions was required to minimize chemical degradation and to inhibit polymorphic 
transformation of gabapentin. Both the size of the extruded granules and gabapentin degradant 
level correlated positively with the specific rate, the ratio between feed rate and screw speed. At 
higher specific rate, the barrel was filled to a greater extent. The material packing and 
compressive forces were enhanced, as proven by the increased rupturing of CAMES® sensor 
beads and GABA crystal size reduction. This resulted in more interaction between the powder 
particles and facilitated granule growth. Simultaneously, this also resulted in higher degradant 
level. To attain adequate tabletability, the specific rate must reach a threshold value. The 
development of an optimum TSMG process requires balancing processing parameters based on 








3 Kittikunakorn, N., Sun, C. C., & Zhang, F. (2019). Effect of screw profile and processing conditions 
on physical transformation and chemical degradation of gabapentin during twin-screw melt 
granulation. European Journal of Pharmaceutical Sciences, 131, 243-253. 






In pharmaceutical manufacturing, powder blends are commonly granulated in order to (1) 
prevent material segregation, (2) improve flow properties, and (3) improve tabletability. Melt 
granulation is a water and solvent-free process where a molten binder at an elevated temperature 
enables granulation under shear followed by solidification when cooled to room temperature 
(Royce, Suryawanshi, Shah, & Vishnupad, 1996). Even though less commonly used than other 
granulation technologies, melt granulation offers unique advantages. In comparison to high-shear 
wet granulation and fluid-bed granulation, one major advantage of melt granulation is that 
solvent mediated chemical degradation (e.g., hydrolysis) and solid state changes (e.g., salt 
disproportionation) are avoided since no water or solvent is used (Kowalski, Kalb, Joshi, & 
Serajuddin, 2009) (Nie, Byrn, & Zhou, 2017). Another major advantage of melt granulation is 
that the tabletability of granules is generally improved, which is in contrast to the usual 
deterioration in tabletability of granules prepared by dry granulation or high-shear wet 
granulation  (Shi, Feng, & Sun, 2011; Sun, C. C. & Kleinebudde, 2016). 
Traditionally, melt granulation process is carried out in jacketed batch mixers, such as 
high-shear and fluid-bed granulators. During batch melt granulation, only low melting point 
binders, e.g., PEG 8000 and waxes, can be used because of the low mixing intensity and 
efficiency. At the same time, potential thermal degradation of drugs by the exposure to an 
elevated temperature during twin-screw extrusion is a major drawback, especially if the drug is 
thermal labile (Haser & Zhang, 2018).  These low melting point binders, however, exhibit a 
limited ability to improve granule tabletability. Some thermoplastic binders, such as 
hydroxypropyl cellulose (HPC), can profoundly improve granule tabletability when coated on 
particle surfaces; however, they cannot be used in batch melt granulation because very high 
temperatures are required for successful granulation in the batch mode (Batra, A., Desai, D., & 
Serajuddin, A. T. M., 2017). However, they can be used in twin screw melt granulation (TSMG) 
because, in addition to heating by the barrel, frictional and viscous heat dissipation occurs at the 
particle-particle or particle-screw/barrel contact surfaces driven by the rotating screws 
(Kittikunakorn, N., DiNunzio, Martin , et al., 2018).  Consequently, the elevated temperature 
from frictional and viscous heat dissipation happens at local contact points instead of the whole 




excessively high temperature.  In addition, the short residence time (usually < 30 seconds) during 
TSMG further reduces any possible thermal degradation (Mu & Thompson, 2012). One 
commercial product that involves TSMG in its manufacturing is Eucreas™ where TSMG of 
metformin-hydroxypropyl cellulose (HPC) granule was used for making immediate-release 
tablets (Lakshman et al., 2011b). In this case, TSMG was used because it is more effective than 
wet granulation and roller compaction in improving the flowability and tabletability of 
metformin.  
As an inherently continuous process, TSMG can be readily integrated into the continuous 
manufacturing of pharmaceutical dosage forms.  With the recent surge of interest in continuous 
manufacturing (Lee, 2017), TSMG has attracted much attention. The commercial successes 
discussed earlier highlight the potential of TSMG in pharmaceutical manufacturing. However, 
clearer understanding of TSMG through systematic studies is needed for the pharmaceutical 
industry to fully embrace this granulation process (Monteyne, Vancoillie, Remon, Vervaet, & De 
Beer, 2016a).  
Despite the clear advantages TSMG offers, one major concern that slows its adaption by 
the pharmaceutical industry is the potential chemical and physical instability of drug substances 
during TSMG.  Chemical stability of drug substance has not been extensively studied in the 
context of TSMG. Polymorphic changes during TSMG have been reported but have not been 
systematically correlated with processing conditions (Monteyne, Tinne et al., 2016). Hence, there 
is a need for systematic understanding of the level of risks in chemical degradation and solid 
form change to facilitate a broader adoption of TSMG by the pharmaceutical industry. 
During TSMG, drug substance could undergo process-induced form transformation via 
kinetic trapping and relaxation mechanisms (Morris et al., 2001).  A metastable form of drug 
becomes stable inside the barrel under the conditions induced by the mechanical and thermal 
stresses.  Upon exiting the extruder barrel, this metastable form should “relax” to a stable form at 
ambient conditions, thermodynamically speaking.  However, the time course of this relaxation 
depends on the characteristics of the process at the molecular level.  If the cooling of the granules 
is fast, drug might be kinetically trapped as metastable form following TSMG. Processing-
induced transformations of drug crystals during pharmaceutical manufacturing are well known 




This study is aimed at mechanistically understanding the effect of screw profile and 
processing conditions on polymorph transformation and chemical degradation during TSMG, 
using gabapentin (GABA)–hydroxypropyl cellulose (HPC) as a model formulation (Figure 4.1).  
GABA is a used here because it undergoes both chemical degradation and solid form changes at 
elevated temperatures (Hsu, C. H. et al., 2010; Zong, Z. X. et al., 2011).  The selection of HPC as 
a thermoplastic binder is based on its effectiveness in improving tabletability (Picker-Freyer, K. 
& Dürig, T., 2007). HPC is an amorphous thermoplastic polymer with a glass transition 





Figure 4.1  Chemical structure of (A) gabapentin (GABA) and (B) hydroxypropyl cellulose 
(HPC). 
4.3 MATERIALS AND METHODS 
4.3.1 Materials 
Gabapentin (GABA, Form II) was purchased from ShenZhen Nexconn Pharmatechs 
(Shenzhen, China). GABA has water solubility of 100 mg/mL at 25 oC and a melting point of 
174°C. Hydroxypropyl cellulose (HPC, Klucel® EXF) was a gift from Ashland Inc. 
(Wilmington, DE).  All other chemicals were of ACS grade or higher. Calibrated 
Microencapsulated Sensor (CAMES) beads (Mach 1 Inc., King of Prussia, PA) were used to 
measure the mechanical stress inflicted onto formulation during melt granulation. The CAMES 
beads in the size range of 54-63 µm and rupture shear stress of 300 kPa were used in this work. 
A powder consisting of 80% (w/w) GABA and 20% (w/w) HPC was prepared by mixing with 25 



















1 A 0.60 100 1250 Runs 1 and 2 are used to evaluate the effect of screw 
profile, specifically kneading elements. 2 B 0.60 100 750 
3 B 0.30 100 300 Runs 3 through 14 are used to evaluate the effect of 
processing conditions, specifically feed rate and screw 
speed, on the physicochemical properties of GABA 
granules.  
4 B 0.30 150 220 
5 B 0.30 200 222 
6 B 0.30 300 120 
7 B 0.45 100 460 
8 B 0.45 150 375 
9 B 0.45 200 345 
10 B 0.45 300 220 
11 B 0.60 100 750 
12 B 0.60 150 415 
13 B 0.60 200 370 
14 B 0.60 300 315 
15 B 0.30 300 120 Containing CAMES beads at 1% to evaluate the 
mechanical stress at two extremes of the specific rate. 16 B 0.60 100 750 





Figure 4.2  Barrel configuration and screw profile with open-end discharge (A) two 60° offset 
neutral kneading blocks, (B) two 30° offset forward kneading blocks. 
GFA X-XX-XX Co-rotating conveying screw-trilobal screw-pitch length (mm)-screw length (mm). 
KB X-X-XX-XX Kneading block-number of kneading segment-screw length (mm)-the angle (°).0d to 26d Length to diameter 
ratio (total barrel length is 420 mm; barrel diameter is 16 mm). 
                                                                                                                                                                                                          
 
 







4.3.2.1  Twin-screw melt granulation 
All extrusion experiments were performed on a co-rotating twin screw extruder (Nano-
16, American Leistritz Extruder Corp., Somerville, NJ), where tri-lobal screw elements were 
used. A twin-screw volumetric feeder (Brabender Technologie, Ontario, Canada) was used to 
control the powder feed rate. The barrel was divided into four zones. The feeding zone was 
maintained at room temperature with water circulation. The barrel temperatures at zones 1, 2, 
and 3 were set at 70°C, 110°C and 110°C, respectively. The barrel temperature was selected 
based on the soften temperature of HPC at 100-120°C. The extruder was operated without a die 
using screw designs detailed in Figure 4.2. The feed rate and screw speed were systematically 
varied as needed (Table 4.1). Both barrel temperature and torque were monitored throughout the 
study. Each sample was collected when steady torque and barrel temperature were attained 
(usually around 5 min after parameters were adjusted). As granules were exiting the barrel, their 
temperature was measured using a visual infrared thermometer (Fluke®, VT04A, FLUKE, 
Everett, WA) that blends a visual image with infrared heat map overlay. The distance between 
the thermometer and granules was kept at 5 cm. 
4.3.2.2  Granule size distribution 
Granule size distribution was characterized using a Dynamic Image Analyzer (Retsch 
Camsizer® P4, V.4.2.1., Haan, Germany). Approximately 10 g of granules was poured into the 
feeder of the instrument.  Images of the falling granule were captured by a camera (CCD-Basic 
and CCD-Zoom) with an image rate of 100% (60 images per second). The covered area of the 
image at which the measurement was included was 2%. The feeder control level for advancing 
the material from the funnel to the shaft prior to image acquisition and feeder start value for the 
measurement were set at 65 and 55, respectively.  
4.3.2.3  Tabletability of melt-extruded granules 
The size of granules collected following granulated in twin screw extruder were reduced 
with a co-mill (Quadro comil, U5-0516, Ontario, Canada). A screen with round holes (0.032 




µm to 850 µm (60-20 mesh) were collected and mixed with 0.5% magnesium stearate in a 
Turbula® Shaker-Mixer (Glen Mills, Clifton, NJ) at 25 rpm for 3 minutes. The tablets (350 ± 5 
mg) were compressed with a manual tablet compression machine (MTCM-I, Globe pharma, NJ, 
USA) using flat-faced, round (11 mm diameter) tooling. Tablet hardness, thickness, and diameter 
were recorded, and the tensile strength (MPa) of the tablets from each formulation was 




 Equation 4.1 
where F, D and H denote the tablet hardness (N), tablet diameter (mm) and tablet 
thickness (mm), respectively. The compression force ranged from 3 to 12 KN. A total of 5 
tablets were prepared and tested under each set of conditions. 
4.3.2.4  HPLC analysis of GABA and its degradant 
GABA granules were stored in a desiccator at ambient conditions prior to analysis. 
GABA and GABA-L contents were analyzed with a Thermo Scientific Dionex Ultimate 3000 
HPLC system (Thermo Scientific, Sunnyvale, CA, USA). An Ultimate 3000 autosampler was 
utilized to inject 20-µl samples. The HPLC system also included dual Ultimate pumps and an 
Ultimate RS variable wavelength detector operating at 210 nm. The mobile phase consisted of 
60% (v/v) water, 30% (v/v) methanol and 10% (v/v) acetonitrile. An isocratic flow at 0.8 
mL/min was used. Injections were passed through an Inertsil® ODS-2, C18 reverse phase 
column, 4.6 x 150 mm, with 5 µm packing, (GL Sciences Inc, Japan) kept at room temperature. 
The retention times of GABA and GABA-L were approximately 3.2 min and 12.8 min, 
respectively. The standard and sample solutions were diluted using highly purified water to 
achieve GABA concentrations in the linear range of the calibration curve (0-10 mg/ml).  Diluted 
solutions were sonicated and filtered through a 0.45 µm Nylon membrane prior to HPLC 
analysis. Chromeleon Version 6.80 software (Thermo Scientific, Sunnyvale, CA, USA) was used 





4.3.2.5  Particle size of gabapentin in melt-extruded granules 
To determine the particle size of GABA in the TSMG granules, granules were dispersed 
in acetone, which does not dissolve GABA but readily dissolves HPC. GABA particles were 
then recovered by filtration and analyzed on a laser diffraction sizer (Sympatec Helos, Sympatec 
GmbH, Germany), equipped with a dispersing cuvette and an R3 lens. A background 
measurement was taken with the blank acetone medium in the cuvette. Each GABA dispersion in 
acetone was added to the cuvette drop-wise until the light obscuration was in the range of 10-
25%. Light diffraction data was then collected for 100 ms.  
4.3.2.6  FT-IR analysis 
FT-IR analysis was performed to determine the polymorphic form of GABA in the 
physical mixture and granules using a Thermo Nicolet iS50 spectrometer (ThermoFisher 
Scientific, Waltham, MA) equipped with an attenuated total reflection accessory. Each sample 
was placed on the germanium crystal surface compressed using the built-in pressure tower to 
achieve uniform contact between the solid and the crystal. The samples were analyzed at room 
temperature with the following settings: 4000−600 cm−1, 64 scans, and a resolution of 4 cm−1. 
The peak positions were determined using OMNIC software peak picking function 
(ThermoFisher Scientific, Waltham, MA). 
4.3.2.7  Powder X-ray diffraction (PXRD) 
The polymorphic form of GABA in the physical mixture and granules was determined by 
using a Rigaku Miniflex 600 (Rigaku Americas, The Woodlands, Texas, USA) instrument 
equipped with a Cu-Kα radiation source generated at 40 kV and 15 mA. Samples were scanned 
in continuous mode with a step size of 0.025° over a 2θ range of 5° to 45° at a rate of 2.5° min-1. 
Data was analyzed by MDI Jade 9 software. 
4.4 RESULTS AND DISCUSSION 
The effect of screw profile, specifically the geometry of kneading block, on process-
induced transformation of GABA was investigated initially. Upon the selection of an optimal 




GABA granule size, polymorphic form, chemical stability, crystal defect, and tabletability were 
studied.  
4.4.1 Effect of screw profile (kneading block) 
All four known GABA polymorphs have extensive networks of hydrogen bonding 
between NH3
+ and COO- groups of neighboring zwitterionic GABA in crystals. Form I is a 
monohydrate and forms II through IV are anhydrous. GABA Form II used in this study is the 
most stable form at ambient condition. GABA Form II is known to undergo a form change and 
chemical degradation simultaneously under heating (Hsu, C. H. et al., 2010). Since GABA was 
subjected to elevated thermal and mechanical stresses during TSMG, it was pertinent to assess 
potential processing-induced physical and chemical changes of GABA. 
To study the effect of screw profile, we focused on the kneading-block screw geometry, 
since kneading blocks impose the most intense mixing, thermal stresses, and mechanical stresses 
on the materials.  At kneading blocks, pressure traps are formed to squeeze, shear, and elongate 
the powder blend, leading to powder agglomeration (Thiele, 2018). It was observed in our 
previous study that granulation, chemical degradation, and size reduction of drug crystals for 
GABA-HPC formulations took place predominately at the kneading block (Kittikunakorn, N., 
Koleng, Listro, Sun, & Zhang, 2019). Figure 4.2 illustrates two screw profiles. The processing 
parameters for these two runs (runs 1 and 2) can be found in Table 4.1. Both screw profiles 
consist of forward-conveying and kneading elements. The design of the screw profile was based 
on the results from our prior study (Kittikunakorn, N., Koleng, J.J., et al., 2019) and it was 
intended to minimize GABA degradation. Large-pitch conveying elements were used in this 
study since small-pitch conveying element resulted in higher degree of fill and greater GABA 
degradation in our prior study. Kneading elements were positioned at zone 3 so that granules exit 
the barrel immediately following the granules formation. The only difference between these two 
screw profiles is the geometry of the kneading elements (60 neutral KB7-3-15-60-N for profile 
A vs. 30 forward KB7-3-15-30 for profile B). These two types of kneading elements have 
different stacking angles between adjacent discs. A 60 stacking angle functions as a neutral 
element which conveys material neither forward nor reverse, while a 30 stacking angle indicates 




distributive mixing than a 30 kneading block. As shown in Table 4.1, the extrusion torques were 
650 and 1,300 G.m for screw profiles containing 30 and 60 kneading blocks, respectively. 






Figure 4.3  Polymorphic transformation of GABA determined by (A) XRPD, and (B) FT-IR. 
Processed at 10 g/min and 100 rpm with 30 forward or 60° neutral kneading block. 
GABA polymorphs differ in the region of 1700 - 1500 cm-1 in their FT-IR spectra.  The 
peak at 1615 cm-1 is the characteristic band of C=O stretching vibration of COO- group and the 
peak at 1546 cm-1 is from N-H scissoring vibration of NH3
+ group. In the spectrum for the melt-




wave number (from 1615 to 1620 cm-1), N-H peak shifted to a lower wave number (from 1546 to 
1522 cm-1), and a new strong peak appeared at 1571 cm-1. These FTIR peaks correspond to the 
characteristic peaks of GABA form IV. Thus, conversion of Form II to Form IV took place 
during TSMG when a 60 kneading block was used.  The results from FT-IR analysis were 
supported with those from XRPD analysis (Figure 4.3B). With 60 kneading blocks, the 
characteristic diffraction peak of Form II at 7.3 degree 2 angle was absent in the XRPD pattern 
of melt-extruded granules, while the characteristic diffraction peak of Form IV at 6.3 degree was 
observed (Hsu, C. H. et al., 2010). In comparison, these changes were absent in FT-IR spectra 
and XRPD patterns of granules prepared using the 30 kneading blocks. We attributed the solid 
form change associated with the use of 60o kneading blocks to the higher thermal and 
mechanical stresses arising from higher frictional and viscous heat dissipation. Based on these 
findings, the screw profile 30 containing kneading blocks (Figure 4.2B) was used for the 
remainder of the study (runs 3 through 16, Table 4.1). 
GABA form IV becomes stable inside the barrel under the conditions induced by the 
mechanical and thermal stresses.  Upon exiting the extruder barrel, form IV should “relax” to 
form II at ambient conditions, thermodynamically speaking.  However, the cooling of the 
granules was so fast that GABA was kinetically trapped as metastable form IV following TSMG. 
4.4.2 Effect of processing condition on the physicochemical properties of GABA granules 
The effects of processing condition on the granule attributes, such as size, shape, and 
strength have been studied (Liu, Y., Thompson, & O'Donnell, 2018; Monteyne, T., Vancoillie, 
J., et al., 2016a). However, the effect of processing conditions on the chemical stability and 
polymorphic transformation has not been systematically investigated. 
To evaluate the effect of processing conditions on the properties of GABA granules, 
twin-screw melt granulation was carried out using screw profile B (Figure 4.2). The highest 
torque used in this part of the study was 750 G.m because greater than 0.4% GABA-L impurity 
content accepted by USP and process-induced transformation were observed when the torque 
exceeded 1,200 G.m. 
One of our objectives is to identify a correlation between physicochemical properties of 




parameters and system parameters. Machine parameters, e.g., feed rate, screw speed, and screw 
profiles, can be controlled directly. System parameters, such as specific mechanical energy, shear 
rate, and specific rate, are functions of both the machine parameters and material properties.  
System parameters are machine independent. Certain system parameters should be kept the same 
during process scale-up in order to achieve the same quality attributes (Haser et al., 2018) 
4.4.2.1 Effect of screw speed and feed rate on GABA granule size 
Full factorial designs of experiment were performed by three feed rates (5, 7.5 and 10 
g/min) and four screw speeds (100, 150, 200 and 300 rpm) as shown in (Table 4.1). When other 
things are equal, granule size increased with an increase in feed rate or a decrease in screw speed 
(Figure 4.4). This may be explained by considering the specific rate, the ratio between feed rate 
and screw speed.  As a very useful system parameter to describe twin-screw extrusion, specific 
rate indicates the degree of the available barrel volume filled by the powder. It strongly 
influences compressive/shear stresses applied to the formulation. At a higher specific rate, the 
material packing and compressive forces between the screws were higher. As a result, the more 
extensive interactions between the powder particles, or the yet developed granules, led to greater 
extend of granule growth. A sigmoidal correlation between the granule size and the specific rate 
is observed in this work (Figure 4.5). Similar effects of screw speed and feed rate were reported 
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Figure 4.4  Images of melt-extruded granules processed at various processing conditions; feed 
rate: 5 g/min, 7.5 g/min, or 10 g/min; screw speed: 100 rpm, 150 rpm, 200 rpm, or 300 rpm. 
 
Figure 4.5  Correlation between granules size (D50) and specific rate of melt granulation process 




4.4.2.2 Effect of screw speed and feed rate on both polymorphic form stability and 
disorder of GABA crystals 
When compared to the physical mixture, no changes in GABA solid form were detected 
in TSMG granules prepared using different feed rates and screw speeds by both FTIR and XRPD 
techniques. Representative FT-IR spectra and XRPD profiles of granules prepared at the lowest 
and highest specific rates are shown in Figure 4.6 and Figure 4.7, respectively. 
As the result of thermal and mechanical stresses during TSMG, amorphous GABA and 
disordered GABA crystal lattice in GABA granules may have a significantly negative impact on 
the physical and chemical stability of GABA (Adrjanowicz et al., 2011) (Fukuoka, Makita, & 
Yamamura, 1986). Greater molecular mobility in amorphous materials and disordered crystals 
allows for greater and faster chemical degradation (Makoto & Nobuyoshi, 1990). 
 
 
Figure 4.6  ATR-FTIR spectra of GABA and HPC raw materials, their physical mixtures, and 





Figure 4.7  XRD pattern of GABA-HPC physical mixture and melt-extruded granules processed 
at highest (0.10 g/min/rpm – 10 g/min at 100 rpm) and lowest (0.0167 g/min/rpm – 5 g/min at 
300 rpm) specific rates (Q/N). 
4.4.2.3 Effect of screw speed and feed rate on GABA chemical stability 
GABA undergoes intramolecular cyclization to form beta-lactam (GABA-L) at elevated 
temperatures. GABA-L is a genotoxic impurity with a USP specification of less or equal to 
0.4%. The thermal stress during melt granulation could lead to GABA degradation. Even though 
heat did conduct from the barrel to granules, the primary source of thermal stress in TSMG is 
from the dispersive and distributive mixing of the rotating screws, which generates thermal stress 
via viscous and frictional heat dissipation. As a result, the temperature of GABA granules ranged 
from 120 to 130C, 10 to 20C higher than the barrel temperature of 110C. 
GABA-L content in the melt-extruded granules was affected by both machine parameters, 
i.e., screw speed and feed rate, and was higher at a higher feed rate and lower screw speed 
(Figure 4.8). Another process parameter, specific mechanical energy (SME), may be potentially 
used to correlate with GABA-L level. SME represents the amount of power generated by the 
motor that input into each kg of the material processed. SME can be calculated using 
Equation 4.2.  
SME =
KW (motor rating) × % Torque ×
RPM running
RPM max











Figure 4.8  GABA-L content of melt-extruded GABA granules processed at various combination 
of screw speeds and feed rates (error bar represents the standard deviation of triplicate analyses). 
For amorphous solid dispersions, higher levels of degradation generally correlate with 
higher SME, as in the meloxicam and copovidone formulation (Haser, A., Huang, S., Listro, T., 
White, D., & Zhang, F., 2017).  However, there was no clear correlation between GABA-L level 
and SME (Figure 4.9A). Instead, a positive roughly linear correlation between GABA-L level 
and specific rate is observed (Figure 4.9B). This correlation may be explained in the same way as 
the observed correlation between granule size and specific rate (Figure 4.5).  In Figure 4.10, 
GABA-L level was plotted as a function of granule size to further illustrate that the same mixing 
mechanisms contributed to both the granule growth and GABA degradation. Heating of the 
formulation is required for both granule growth and GABA degradation. Both frictional heat 
dissipation and heat conducted from the barrel contributed to the heating of the formulation.  At 
a higher specific rate, the degree of fill was higher. As a result, the heat transfer from the barrel 
to the formulation became more efficient. Our hypothesis is that heat conducted from the barrel 









Figure 4.9  Relation between GABA-L content of melt-extruded GABA granules and system 
parameters of melt extrusion. (A) Specific mechanical energy, and (B) Specific rate.  
 
Figure 4.10  Correlation between GABA-L content and the size of melt-extruded GABA 
granules.  
Particle sizes of GABA crystals in the melt-extruded granules may be used to probe the 
mechanical stresses during TSMG, as higher mechanical stresses likely cause more GABA 
crystal fracture and size reduction. Particle size distribution profiles of extracted GABA crystals 
in melt-extruded granules prepared at the lowest (5 g/min and 300 rpm) specific rates were the 
same as GABA drug substance (Figure 4.11), indicating minimal mechanical stress during 
TSMG. In contrast, D50 of GABA dropped from 64 µm to 18 µm at the highest specific rate at 




mechanical stress. Following a significant drop initially, GABA D50 did not significantly 
decrease once the specific rate reached 0.03 g/min/rpm (Figure 4.12). This implies that the 
critical brittle-ductile transition size of GABA is 10 – 20 µm under the conditions employed in 
this work (Kendall, 1978). At or below the critical size, reduction of GABA by crack 
propagation is impossible. 
 
Figure 4.11  Particle size distribution of gabapentin (GABA) drug substance and GABA crystals 
in the melt-extruded granules at highest (0.10 g/min/rpm – 10 g/min at 100 rpm) and lowest 
(0.0167 g/min/rpm – 5 g/min at 300 rpm) specific rates. 
 
Figure 4.12  Correlation between D50 of GABA crystals in the melt-extruded granules and 




The effect of specific rate on the mechanical stress during TSMG was confirmed using 
CAMES beads. CAMES beads are microcapsules consisting of a cross-linked polymeric shells 
with dye-containing cores manufactured using a coacervation process. Calibrated shear stress 
levels of CAMES beads are provided by the manufacturer. When mechanical stresses during 
TSMG exceed the strength of the shell, CAMES beads rupture to release the encapsulated 
AUTOMATE blue 8A dye. CAMES beads have been used to measure stress distribution during 
twin-screw polymer compounding (Balakrishnan, Dryer, & Bigio, 2017). CAMES beads (54-63 
𝜇m in diameter, 330 kPa strength) were incorporated into GABA-HPC blend at 1% level. Once 
the extrusion reached a steady state, the extruder was stopped, and the screws were pulled out 
immediately. GABA granules were sampled at different axial positions and the concentration of 
the released dye in GABA granules was measured using LC-MS. As mentioned before, GABA 
degradation occurred predominately over the kneading blocks. CAMES beads rupture 
continuously along the axial direction of the screw under both the lowest (5 g/min and 300 rpm) 
and highest (10 g/min and 100 rpm) specific rates. 80% of beads ruptured even prior to entering 
the kneading block at the highest specific rate, while a maximum of 40% of beads ruptured at the 
lowest specific rate (Figure 4.13). Thus, mechanical stresses are on average greater at higher 
specific rate. However, the impurity profile (Figure 4.13A) increased exponentially as compared 
to the linear increase of the percentage of rupture for CAMES sensor (Figure 4.13B). It was 
















Figure 4.13  (A) The percentage of GABA degradant and (B) CAMES beads breakage along the 
axial direction at the highest (0.10 g/min/rpm – 10 g/min at 100 rpm) and lowest 
(0.0167 g/min/rpm – 5 g/min at 300 rpm) specific rates. (n=3, mean value and standard deviation 
are reported) 
4.4.2.4 Effect of processing condition on the tabletability of GABA granules 
The primary motivation of GABA TSMG is to improve its tabletability since GABA 
exhibits poor tabletability and is a high dose drug (Jagdale, Kuchekar, Satapathy, & Chabukswar, 
2010a). We had previously shown that the surface of TSMG GABA-HPC granules is enriched 
by HPC (Kittikunakorn, N., Koleng, J.J., et al., 2019). This spatial arrangement of HPC is 
expected to significantly improve tabletability of GABA granules as surface modification is 








Figure 4.14  (A) Compression profiles of physical mixture and melt-extruded granules processed 
at high and low degree of fill and (B) correlation between tensile strength of the tablets prepared 
at 100 MPa compression pressure and the tensile strength of tablet. (n=5, mean value and 
standard deviation are reported) 
The tabletability, i.e., tablet tensile strength as a function of compression pressure, of the 
TSMG granulates (20-60 mesh) prepared at the highest specific rate is significanlty higher than 
those of the physical mixture and the granule prepared at the lowest specific rate (Figure 4.14A). 
Tablets with tensile strength of equal to or greater than 2 MPa are considered to have sufficient 
mechanical strength (Osei-Yeboah, F. & Sun, C. C., 2015b). By this measure, the tabletability of 
GABA granules processed at the lowest specific rate (5 g/min and 300 rpm) physical blend is 
deficient, since tensile strength barely reached 1 MPa at the highest pressure of 120 MPa used in 
this study (Figure 4.14A). Granules processed at the highest specific rate (10 g/min and 100 rpm) 
could reach 2 MPa tensile strength even at 60 MPa. The significantly improved tabletability of 
the granules prepared at the highest specific rate is attributed to the efficient spreading and 
coating of HPC on the GABA surface, which was inadequate at the lowest specific rate.  In 
Figure 4.14B, when plotted against specific rate, the tensile strength of tablets at 100 MPa 
compaction pressure for all granules jumped to above 2 MPa when the specific rate reached 
0.03 g/min/rpm.  This corresponds to change in GABA crystal reduction (Figure 4.12).  
Therefore, the smaller GABA size likely also contributed to the improved tabletability at the 




distributed in a range of 2.2 to 3.3 MPa. Therefore, the tabletability enhancement was robust 
once the threshold specific rate was reached. 
4.5 CONCLUSIONS 
Process-induced transformation and chemical degradation of gabapentin during TSMG 
have been investigated using a formulation containing 20% HPC Klucel EXF. The 60 neutral 
kneading block led to significantly higher thermal and mechanical stresses, which caused more 
significant GABA conversion from form II to form IV. The usage of a 30 forward kneading 
block in combination with a low extrusion torque was required in order to prepare GABA 
granules with no polymorphic transformation and good chemical stabilities (GABA-L level 
below 0.15%). Under these machine parameters, a higher specific rate was found to lead to larger 
extruded granules, smaller GABA crystals, and higher tabletability, but also higher degradant 
content in GABA granules. This was attributed to the higher mechanical stresses at higher 
specific rate, which was proven using CAMES sensors. Thus, a successful TSMG process 
requires a balance between achieving sufficient granule growth to improve tabletability, process-
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5 Chapter 5: Is the Melt Granulation Behavior Same between Leistritz Nano-16 
and Micro-18 Extruders? 
 
5.1        ABSTRACT 
Using 80% Gabapentin and 20% hydroxypropyl cellulose (Klucel) blend as a model 
formulation, we investigated how differences in mixing elements geometry between the Leistritz 
Nano-16 and Micro-18 extruders affect granulation mechanisms and granule properties. Because 
of their thinner discs (2.5 mm wide), kneading blocks in Nano-16 are less efficient in dispersive 
mixing than kneading blocks in the Micro-18. Therefore, the formulation could only be 
granulated under a higher degree of fill (DF) by enhancing axial compaction and heating by the 
barrel. In contrast, efficient dispersive mixing by the kneading blocks (5 mm wide) in the Mico-
18 enabled granulation without axial compaction and barrel heating.  Higher specific mechanical 
energy (SME) achieved at higher screw speeds and lower feed rates (lower DF) led to a greater 
degree of granulation. Because of the difference in granulation mechanisms between the two 
extruders, correlations between granule properties and processing parameters is different 
between the two extruders. Tabletability and degradant content of granules correlated positively 
with DF for the Nano-16 and with SME for the Micro-18. 
5.2        INTRODUCTION 
Granulation processes are commonly used in pharmaceutical manufacturing to (1) 
prevent segregation, (2) ensure uniformity (Pandey & Badawy, 2019), (3) improve flow, and (4) 
enhance the tabletability of powder blends (Batra, A. et al., 2017). Various granulation technique 
such as wet, melt, and dry granulation can be used to granulate powders (Parikh, 2005). 
Granulation is traditionally carried out in batch process. In order to achieve better process control 
and consistency in product quality, the transition of wet and melt granulation from batch to 
continuous process using twin-screw extruders has recently drawn significant interest in the 




 Twin-screw melt granulation (TSMG) is a continuous and solvent-free process which is 
suitable for both water and solvent-sensitive drug substances (Ghebre-Sellassie, I. et al., 2002). 
TSMG can effectively improve the tabletability of a drug substance by modifying the surface of 
drug crystal with molten binder, which solidifies upon cooling after exiting the extruder 
(Kittikunakorn, N., Sun, C. C., et al., 2019). The successful application of TSMG to the 
manufacture of Eucrease™ tablets (TSMG of metformin with hydroxypropyl cellulose) has 
drawn the pharmaceutical industry’s interest to this process (Lakshman et al., 2011a). However, 
one of the major limitations of TSMG is the undesired physicochemical changes it can induce in 
drug substances during processing. The granule temperature is elevated as a result of the heat 
conducted from the barrel and of the viscous heat dissipation by the rotating screws 
(Rauwendaal, 2016). Elevated thermal and mechanical stresses cause undesired process-induced 
transformations of drug substances. Polymorphic changes and chemical degradation of drug 
substances during TSMG have been reported (Kittikunakorn, N., Sun, C. C., et al., 2019; 
Lakshman et al., 2011a). Therefore, a systematic study of the process-induced physicochemical 
changes of drug substances in TSMG is needed to facilitate broader adoption and better process 
design for TSMG by the pharmaceutical industry. 
Table 5.1  Differences of machine and screw geometry at kneading zone between Leistritz Nano-
16 and Micro-18 extruders 
Parameter Nano-16 extruder Micro-18 extruder 
Screw configuration 
  
Screw diameter (mm) 16 18 
Overflight gap (mm) 0.05 0.1 
Maximum channel depth (mm) 1.2 3.1 
Free volume (cc./dia) 1 3.2 
Disc width of kneading element (mm) 2.5 5 
Disc stacking angle of kneading element* 30 30 
* tri-lobal kneading element for Nano-16 vs. bi-lobal kneading element for Micro-18. Neutral position would 
be 60 and 90 for Nano-16 and Micro-19.  Therefore, from stacking angle perspective, the kneading 




The Leistritz Nano-16 and Micro-18 are co-rotating twin-screw extruders commonly used 
at different stages of product development. As shown in Table 5.1, the Nano-16 extruder (trilobal 
screw element) is designed with a minimal free volume to enable preclinical development with a 
small amount of material (< 50 g). The ratio between barrel length and inner diameter of the 
barrel is 26:1 for the Nano-16. Trilobal screw elements in the Nano-16 have 15.9 mm outer 
diameters. In comparison, the Micro-18 extruder has a higher free volume and is used to support 
phases 1 through 3 clinical trials (0.5 to 4 kg per hour production rate). Bilobal screw elements in 
the Micro-18 have 17.8 mm outer diameters. The ratio between barrel length and inner diameter 
of the barrel is 25:1 for the Micro-18. The Micro-18 offers several advantages, such as ability to 
scale-up and flexible process design and control (e.g., side stuffing, downstream feeding, and 
vacuum) (Martin, 2013a).  
TSMG of Gabapentin (GABA) and hydroxypropyl cellulose (Klucel) using the Nano-16 
extruder was investigated in our prior study (Kittikunakorn, N., Sun, C. C., et al., 2019). As a 
high-dose drug (up to 800 mg per tablet) with poor compaction properties, GABA requires 
tabletability improvement via granulation (Jagdale, Kuchekar, Satapathy, & Chabukswar, 
2010b). Klucel is a highly effective polymeric binder in tabletability enhancement (Picker-
Freyer, K. M. & Dürig, T., 2007). A low glass transition temperature of 20°C  and a softening 
temperature between 100 and 120°C (Rials & Glasser, 1988) make Klucel an ideal thermal 
binder for TSMG. GABA was selected as a model drug because of its poor thermal stability. It 
undergoes intramolecular cyclization followed by dehydration to yield gabapentin-lactam 
(GABA-L) at elevated temperatures (Zong, Z., Qiu, Tinmanee, & Kirsch, 2012). GABA consists 
of four polymorphic forms, of which Form II is the most stable. Form I is the monohydrate form 
and Form II-IV is the anhydrous form (Reece & Levendis, 2008). Under mechanical stress such 
as milling, GABA was reported to undergo process-induced polymorphic transformation (Lin, 
Hsu, & Ke, 2010; Tinmanee, Stamatis, Ueyama, Morris, & Kirsch, 2018). In our prior study of 
GABA TSMG using the Nano-16, the degree of fill (DF) was identified to be the critical 
processing parameter controlling the physicochemical properties of granules (Kittikunakorn, N., 
Sun, C. C., et al., 2019). However, in order to achieve higher throughput and more flexible 




Transition of TSMG from the Nano-16 to the Micro-18 extruder is complex due to 
differences in machine parameters such as screw geometry and free volume. Djuric et al. 
reported that differences in granule formation were observed between two twin-screw extruders 
(APV Baker and Leistritz), leading to the differences in granule properties such as flowability, 
porosity, and tensile strength. They concluded that these two extruders cannot be simply 
interchanged without further geometric optimization (Djuric, D., Van Melkebeke, Kleinebudde, 
Remon, & Vervaet, 2009).   
Therefore, the amins of our study are (1) to investigate the differences in granulation 
mechanisms, and (2) to determine the differences in the granulation process-granule properties 
correlation between the Nano-16 and the Mico-18. Granule properties focus on GABA 
physicochemical stability and tabletability. 
5.3        MATERIAL AND METHODS 
5.3.1   Material 
Gabapentin (GABA, Form II) was purchased from ShenZhen Nexconn Pharmatechs 
(Shenzhen, China). GABA has a melting point of 174oC and water solubility of 100 mg/ml at 
25oC. Hydroxypropyl cellulose (KlucelTM EF) was kindly donated from Ashland Inc. 
(Wilmington, DE). All other chemicals were ACS grade or higher.  
5.3.2   Methods 
5.3.2.1  Twin-screw melt granulation 
A powder consisting of 80% (w/w) GABA and 20% (w/w) Klucel was prepared by 
mixing in a V-shape blender (MaxiBlend, GlobePharma, New Brunswick, NJ) at 25 rpm for 10 
min. All experiments were carried out using a Leistritz Nano-16 or Micro-18 co-rotating twin-
screw extruder (American Leistritz Extruder Corp., Somerville, NJ). A twin-screw volumetric 
feeder (Brabender Technologies, Ontario, Canada) was used to control the feed rate. For the 
Nano-16, the barrel was divided into four zones. The barrel temperatures at zones 1 through 4 
were maintained at 25°C, 70°C, 110°C, and 110°C, respectively. The temperatures were chosen 
based on the softening temperature of Klucel at 100-120°C. For the Micro-18, the barrel was 




circulation. The barrel temperature from zone 2 to zone 5 was set at 60°C. Both the Nano-16 and 
the Micro-18 were operated with an open-end discharge configuration. The screw design used in 
each extruder is presented in Figure 5.1. Steady state torque was recorded throughout the study. 
Granule temperature was measured with a non-contact infrared thermometer (Fluke, VT04A, 
Everett, WA). Screw speed and feed rate were systematically varied as listed in Table 5.2.  
A) Zone 1      Zone 2    Zone 3 Zone 4  




B) Zone 1 Zone 2 Zone 3 Zone 4 Zone 5 
 Condition 1:        70°C    70°C 110°C   110°C 
 Condition 2:        60°C    60°C 60°C    60°C 
 
 
Figure 5.1  Barrel configuration, screw profile with open-end discharge, and barrel temperature 
of (A) Nano-16 (B) Micro-18 twin-screw extruder. 
GFA X-XX-XX Co-rotating conveying screw-trilobal screw-pitch length (mm)-screw length (mm). 
KB X-X-XX-XX Kneading block-number of kneading segment-screw length (mm)-the angle (°). 










































F1 10.0 100 25.0 13.8 129 Barrel temperature of 





formation for Runs 
no. F3 and F6 
F2 10.0 150 16.7 7.2 130 
F3 10.0 200 12.5 2.7 117 
F4 12.5 100 31.3 17.0 133 
F5 12.5 150 20.8 11.1 135 
F6 12.5 200 15.6 2.9 122 
F7 15.0 100 37.5 20.0 136 
F8 15.0 150 25.0 12.9 138 
F9 15.0 200 18.8 10.3 140 
F10 20.0 100 50.0 24.3 140 
F11 20.0 150 33.3 15.7 145 




















F13 21.3 100 12.5 31 90 Barrel temperature of 
zone 1-4 was set at 
60°C.  
F14 21.3 150 8.3 25 92 
F15 21.3 200 6.2 22 112 
F16 21.3 300 4.2 19 123 
F17 42.7 100 25.0 40 86 
F18 42.7 150 16.7 33 92 
F19 42.7 200 12.5 27 99 
F20 42.7 300 8.3 23 108 
F21 64.0 100 37.5 51 92 
F22 64.0 150 25.0 43 97 
F23 64.0 200 18.8 38 103 
F24 64.0 300 12.5 28 110 
F25 85.3 100 50.0 70 96 
F26 85.3 150 33.3 51 102 
F27 85.3 200 25.0 43 104 
F28 85.3 300 16.7 33 112 
 
5.3.2.2  Assay and impurity content 
Gabapentin and degradant (GABA-L) content were analyzed using a Thermo Scientific 
Dionex Ultimate 3000 HPLC system (Thermo Scientific, Sunnyvale, CA) equipped with dual 
Ultimate pumps and an RS variable wavelength UV detector.  The mobile phase consisted of 
60% (v/v) water, 30% (v/v) methanol, and 10% (v/v) acetonitrile with an isocratic flow rate of 
0.8 mL/min. The standard and sample solutions were prepared to be within the linear 
concentration range of 0-10 mg/mL. Prior to injection, the solutions were filtered through a 0.45 




column (4.6 x 150 mm, with 5 µm packing, GL Sciences Inc., Japan) at room temperature. The 
chromatography data were processed and analyzed using Chromeleon software (Version 6.8, 
Thermo Scienctific, Sunnyvale, CA). The retention times of GABA and GABA-L were 3.2 and 
12.8 min, respectively. The LOD and LOQ of GABA-L were 0.03 and 0.08 µg/mL, respectively.  
5.3.2.3  Enthalpy change during twin-screw melt granulation 
Based on Hess’s law, the enthalpy change of any reaction is independent of the number of 
ways the product can be obtained, as long as the initial and final product are the same. Therefore, 
the enthalpy difference (∆H) between the physical mixture and granules exiting the extruder can 
be calculated by dividing the granulation process into the following two steps shown in Figure 
5.2A. 
Step 1: ∆H between physical mixture and granules at 25°C, and 
Step 2: ∆H between granules at 25°C and granule exiting extruder at elevated 
temperature.  
∆H in Step 1 and Step 2 can be measured and calculated using a solution isothermal 






Figure 5.2  (A) Schematic diagram demonstrating enthalpy measurement using thermodynamic 





a) Solution isothermal micro-calorimetry 
∆H values between physical mixture and granules at 25°C were obtained using 
isothermal micro-calorimeter (TAM IV, TA instrument, New Castle, DE). Experiments were 
performed at 25C, using 0.1 g of each sample and 4 mL of deionized (DI) water at 25C +/- 
0.2C.  Each sample was placed within the calorimeter using the titration cell. Once the 
measured heat signal was moderately stable, the initial baseline for each experiment was 
initiated.  After completion of the initial baseline, the sample was stirred at 150 rev/min for 2.5 
min as 4 mL of DI water was directly injected. The stirring rate was shown to minimally affect 
the heat evolution in relation to the effects of the addition of water and dissolution. The heat 
evolution of a blank sample, that is a sample system containing no powder material before DI 
water was injected, was also monitored, with identical conditions to all other samples analyzed. 
Each sample was monitored for a minimum of 5 hr following water injection.  
b) Differential scanning calorimetry (DSC) 
The heat capacity of granules at various temperature was determined using a differential 
scanning calorimeter (DSC Q20, TA instruments, New Castle, DE). A pair of pans and lids that 
were to be used for the reference and sample were selected so as to have similar weights (±5 
mg). Prior to the heat capacity measurement, the DSC was calibrated using indium, ramping 
from 100 to 180°C at a heating rate of 10°C/min. The onset melting point of indium should be in 
the range at 156.6 ± 0.3°C.  Then MDSC heat capacity calibration was performed using sapphire 
to determine the calibration factor. The sample was heated from 25 to 250°C with a heating rate 
of 3°C/min and an amplitude of 1°C every 120 seconds. The enthalpy change of the sample was 
then calculated using the equation:  
∆𝐻 = ∫ 𝐶𝑝𝑑𝑇
𝑇1
𝑇2
 Equation 5.1 
where ∆H is enthalpy change, Cp is the heat capacity, and T is temperature. 
5.3.2.4  Tabletability of melt-extruded granules 
GABA-Klucel granules were milled using a co-mill (Quadro comil, U5-0516, Ontario, 




between 250 µm to 850 µm (60-20 mesh) were collected. The collected granules were mixed 
with 0.5% (w/w) magnesium stearate in a Turbula® Shaker-Mixer (Glen Mills, Clifton, NJ) at 
25 rpm for 3 min. Tabletability of the granules was characterized using a compaction simulator 
(Presster®, Metropolitan Computing Corporation, NJ, USA). 300 mg of granules were 
compressed with flat-faced round tooling with a 10 mm diameter over a range of compression 
pressures between 25 and 300 MPa. The dwell time and tablet production rate were set at 10 ms 
and 103,000 tablets/hr, respectively. Tablets were kept in the sealed container for two hours to 
allow stress relaxation. The breaking force of the tablets was then measured using a texture 
analyzer (Texture Technologies Corp., Surrey, UK). The speed of the probe was set at 0.01 
mm/s. The tensile strength of the tablets was calculated based on the following equation (Fell & 




 Equation 5.2 
 
where F, D, H represents the breaking force (N), tablet diameter (mm), and tablet thickness 
(mm), respectively.  
5.3.2.5  Granule density 
A multipycnometer (Quantachrome Instruments, Boynton Beach, FL) was used to 
measure the density of the granules along the axial direction of the screw. Immediately after the 
extruder was stopped, the screws were pulled out and granules were sample at various locations. 
Helium controlled at 20 psi was used as the displacement gas in the system. Granules were 
placed in the micro cell to at least 75% of the cell volume, and the sample weight was recorded. 
The sample volume was calculated based on the equation: 
𝑉𝑝 =  𝑉𝑐 − 𝑉𝑟((
𝑃1
𝑃2
) − 1) Equation 3 
where Vp is the sample volume (cm
3), Vc is the cell volume (cm
3), Vr is the reference volume 
(cm3), P1 is the pressure reading after pressurizing the reference volume (kPa), and P2 is the 
pressure reading after including the cell volume (kPa). The granule density was then calculated 
by dividing the sample weight (g) with Vp (cm
3). The measurement was carried out at room 
temperature and repeated three times. It should be noted that as helium gas cannot penetrate 




volume of closed pore inside the granules but excluding the volume of open pore and the void 
between the granules. Therefore, the measured granules density in this study is not true density 
of the material. It can be called apparent density or skeleton density (Webb, 2001) 
5.3.2.6  Binder distribution 
Granules were dispersed in a 20% sodium chloride solution in which GABA can be 
freely dissolved but Klucel is not soluble. Blue dye (Paragon stain) was added in the solution to 
stain Klucel. Samples were kept at ambient conditions for at least 5 hr to allow GABA to 
dissolve and Klucel to be stained.  The remaining scaffold of Klucel was analyzed using a 
compound light microscope in the phase-contrast mode (Nikon Eclipse Ni, Nikon Instruments 
Inc., Japan) at 40x magnification. Images were captured using the NIS-Elements software. The 
resolution and size of captured images were set at 3x8 bit and 4908x3264, respectively. The 
captured images were further processed using ImageJ. The color distribution represents the 
amount of Klucel based on the distribution of dye intensity.  
5.3.2.7  Particle size of GABA in melt-extruded granules 
Particle size of GABA in melt-extruded granules was measured using a laser diffraction 
analyzer with a cuvette dispersing system (Sympatec Helos (R3 lens), Sympatec GmbH, 
Germany). The melt-extruded granules were initially dispersed in acetone for at least 3 hr under 
gentle stirring. Acetone was selected as a dispersing solvent as it readily dissolves Klucel but 
cannot dissolve GABA. During measurement with laser diffraction analyzer, the dispersion of 
GABA in acetone was added dropwise to the cuvette filled with acetone until the light 
obscuration was between 10-25%. The data was collected every 100 ms for 10 sec. 
5.4        RESULTS AND DISCUSSIONS 
5.4.1    Scale-up from Nano-16 to Micro-18 
Scale-up of twin-screw process is generally based on system parameters including degree 
of fill, specific mechanical energy, shear rate, and residence time. In our previous study of 
TSMG of GABA-Klucel using a Leistritz Nano-16, feed rate and screw speed were varied to 




concluded that the degree of fill (DF) is the system parameter that correlated well with the 
properties of granules (Kittikunakorn, N., Sun, C. C., et al., 2019). Therefore, in our initial 
attempt to scale-up from the Nano-16 to the Micro-18, DF was kept the same. The DF is 
calculated based on the conveying elements leading to the kneading elements with the following 
equation (Todd, 1998a): 
%𝐹𝑖𝑙𝑙 =  
𝐹𝑒𝑒𝑑 𝑟𝑎𝑡𝑒
(𝐶𝑟𝑜𝑠𝑠 𝑠𝑒𝑐𝑡𝑖𝑜𝑛 𝑎𝑟𝑒𝑎 𝑥 𝑃𝑖𝑡𝑐ℎ 𝑙𝑒𝑛𝑔𝑡ℎ 𝑥 𝑟𝑝𝑚 𝑥 𝐷𝑒𝑛𝑠𝑖𝑡𝑦)/2
 x100 Equation 5.4 
  
The screw designs used in the Nano-16 and the Micro-18 are shown in Figure 5.1. 
Because polymorphic transformation of GABA was observed with the more aggressive 60° 
kneading element in our previous Nano-16 study (Kittikunakorn, N., Sun, C. C., et al., 2019), a 
30° kneading element was selected for granulation for both the Nano-16 and the Micro-18. The 
barrel temperatures of zone 2 through zone 4 in the Nano-16 were set at 70, 110, and 110°C, 
respectively. At a temperature below 110°C, a powder blend could not be granulated without the 
heat conducted from the barrel. The degradant level ranged from 0.01 to 0.1% in the Nano-16. 
When the same temperature profile was used in the Micro-18, significant degradation (> 0.4%, 
w/w) was observed in the Micro-18. Therefore, a lower barrel temperature (60°C), which was the 
minimum temperature that GABA formulation could be granulated, was used in zones 2 through 
5 to minimize GABA degradation in the Micro-18. The mean residence times of granules 






5.4.2    Correlation between processing parameters and chemical stability of GABA 
granules. Nano-16 vs. Micro-18 










Figure 5.3  Correlation between (A and C) %GABA-L and Degree of fill, (B and D) %GABA-L 
and SME of GABA granules processed using Nano-16 and Micro-18. 
Granulation of 80% GABA and 20% Klucel mixture in the Nano-16 could only occur at 
DF higher than 18% and high barrel temperatures (≥ 110C), while granulation in the Micro-18 
occurred at all DFs ranging from 4.2 to 50% and low barrel temperatures (60C). One of the 
primary granule properties we focused on is GABA chemical stability. Gabapentin lactam 
(GABA-L) is the primary degradant of GABA. As illustrated in Figure 5.3A and Figure 5.3B, 




the Micro-18 (negative). Instead, GABA-L content of GABA granules prepared using the Micro-
18 correlated positively with SME (Figure 5.3D) and granule temperature (Figure 5.4). There 
was no clear trend between GABA-L content and SME in Nano-16 (Figure 5.3C). 
 
Figure 5.4  Correlation between degradant content and the temperature of GABA granules 
prepared using the Micro-18. 
It was hypothesized that the observed difference in granulation behavior arises from 
differences in screw geometry (Table 5.1) between the Nano-16 and the Micro-18. The intensity 
of the mixing of kneading elements depends on screw geometry. A narrow overflight gap, a 
shallower channel, and a more aggressive stacking angle should all result in more intense 
dispersive mixing in the Nano-16. However, disc width plays a more dominant role in mixing. 
As the kneading disc becomes thicker, the more dispersive mixing it provides (Andersen, 2018). 
The width of the kneading disc in the Nano-16 (2.5 mm) is only half of that in Micro-18 (5 mm), 
leading to less-intensive dispersive mixing. As a result, a higher barrel temperature was required 
in the Nano-16 extruder to melt Klucel. Heat transfer between the barrel and processed material 







Figure 5.5  Apparent density of granules sampled along the barrel (A) Nano-16 (operated at the 
feed rate of 15 g/min, screw speed of 100 rpm) (B) Micro-18 (operated at the feed rate 64 g/min, 
screw speed of 100 rpm). 
Additionally, higher DF was required in the Nano-16 to promote granulation by 
increasing the axial mixing and compression. The apparent density of formulation along the 
barrel is shown in Figure 5.5. The formulation density increased prior to kneading zone, 
indicating pre-granulation in the Nano-16. It was concluded that granule formation in the Nano-
16 was largely due to axial compaction and heat conducted from the barrel. However, the higher 
the DF was, the greater the extent of shear stresses the material was exposed to. This led to 
breakage and amorphization of GABA crystals (Kittikunakorn, N., Sun, C. C., et al., 2019). As a 




In comparison, granulation in the Micro-18 only occurred at the kneading element. As 
shown in Figure 5.5, the formulation remained in powder form and was heated to 52-57°C prior 
to entering the kneading element. The melting of Klucel and granulation were all attributed to the 
viscous heat dissipation at the kneading element. The energy input by the kneading element is 
defined by SME. SME represents the amount of power generated by the screw and transferred 
into each unit of mass of the material (Repka, Langley, & DiNunzio, 2013). SME is calculated 
using the equation (Martin, 2013a): 
𝑆𝑀𝐸 =  
𝑘𝑊 (𝑚𝑜𝑡𝑜𝑟 𝑟𝑎𝑡𝑖𝑛𝑔)𝑥 %𝑇𝑜𝑟𝑞𝑢𝑒 𝑥 
𝑅𝑃𝑀 𝑟𝑢𝑛𝑛𝑖𝑛𝑔
max 𝑅𝑃𝑀





 Equation 5.5 
The higher the SME and granule temperature were, the higher the GABA-L content was. 
The correlation between degradant level and SME in the Micro-18 is similar to that for hot-melt 
extrusion of amorphous solid dispersion (Haser, Abbe, Huang, Siyuan, Listro, Tony, White, 
David, & Zhang, Feng, 2017b). The positive correlation between GABA-L content and SME in 
Micro-18 was observed at all powder feed rates (Figure 5.3D).  As screw speed increased from 
100 to 300 rpm, the GABA-L content increased. However, an offset between four feed rates was 
apparent. As a result, the granules processed at the same SME but different feed rate exhibited 
different degradation content. This phenomenon was investigated, and the results are presented 
in the following section.  
5.4.3  Offset between Degradant Content-SME Profiles at Different Feed Rates for the 
Micro-18 
The offset in the degradant content-SME profiles was hypothesized to be due to the 
different heat loss to the barrel as the result of the different residence times. Energy transfer 
during the extrusion process relates to the physicochemical transformation of the material 
(Godavarti & Karwe, 1997). The schematic diagram of the energy flows in a melt granulation 
process is illustrated in Figure 5.6 and the energy balance can be written as follows: 




where SME is specific mechanical energy, Q is the amount of heat transfer between formulation 
and barrel, and ∆H is the enthalpy difference between the material entering and exiting the zone 
5 of the barrel.  
 
Figure 5.6  Schematic diagram showing the energy balance at zone 5 (kneading zone). 
Q is a function of the temperature differential between the material and barrel and the 
residence time of the material. The barrel temperature was set at 60 C to minimize the 
degradation during melt granulation. Due to the dispersive mixing of kneading element, the 
temperature of GABA granules ranged from 86 to 123C, significantly higher than the barrel 
temperature.  Therefore, heat transfer from the granules to the barrel was anticipated. Varying 
the feed rate affects the residence time of material in the filled region where the kneading 
elements were located.  
To further assess our hypothesis, the amount of heat loss during the melt granulation 
process was determined using two different methods: (1) a thermodynamic method and (2) a heat 
transfer method. 
In the thermodynamic method, the heat loss was calculated based on an energy balance of 
the TSMG process. The energy input is equivalent to specific mechanical energy (SME) The 
energy outflow is equivalent to the sum of the heat transferred to the barrel and the enthalpy 
difference between the granules and feed powder (Godavarti & Karwe, 1997). ∆H was measured 
using solution calorimetry (Figure 5.2B) and DSC (Alin et al., 2018). Therefore, the amount of 




In the heat transfer method, Q was measured directly from barrel heating following the 
shut off of the cooling water. Initially, the TSMG was run at the barrel temperature of 60°C with 
cooling water turned on. After the system reached steady state, the water cooling system was 
shut off. With the extruder still running, the increase in barrel temperature at zone 5 (the where 
kneading element is positioned) was recorded at 5 min. The heat loss to the barrel was calculated 
using the following equation: 
𝐻𝑒𝑎𝑡 𝑙𝑜𝑠𝑠 (𝐽 𝑔⁄ ) =  
∆𝑇 𝑥 𝐶𝑝 (𝐽 °𝐶⁄ . 𝑘𝑔) 𝑥 𝑀(𝑘𝑔)
𝐹𝑒𝑒𝑑 𝑟𝑎𝑡𝑒 (𝑔 min )⁄  𝑥 𝑡𝑖𝑚𝑒 (𝑚𝑖𝑛)
 Equation 5.6 
where ∆𝑇 is the temperature difference, Cp is the heat capacity of the barrel (440C stainless 
steel), and M is mass of the barrel.  
 
Figure 5.7  Amount of heat loss to the barrel during granulation process at various feed rates 
calculated by heat transfer method. Each line represents each feed rate operated at screw speed of 
100 rpm ( ), 200 rpm ( ), and 300 rpm ( ). 
Figure 5.7 shows the mearured heat loss at various feed rates calculated from the energy 
required to increase barrel temperature after turning off the cooling system (heat transfer 
method). Higher amounts of heat loss observed at low feed rates were due to a longer residence 
time in the kneading section, promoting the heat loss from the granules to the barrel. Once the 




across all processing conditions. SME-Q or H represents the total energy absorved by the 
material (Figure 5.8). This result confirmed our hypothesis that the offset between SME and 
GABA-L content was due to the different amount of heat loss transferred to the barrel during 





Figure 5.8  (A) The correlation between %GABA-L and specific mechanical energy (B) the 
correlation between %GABA-L and enthalpy difference between the material entering and 
exiting the barrel zone 5. 
5.4.4   Crystal form changes and particle size reduction of GABA 
GABA consists of four polymorphic forms (Form I-IV). Its molecule contains an 
extensive H-bond between -NH3
+ and -COO- groups and can easily form GABA-L via 
intramolecular cyclization (Braga et al., 2008).  It was reported in our previous study that GABA 
underwent polymorphic transformation from the stable Form II to Form IV during TSMG with 
60° kneading elements due to intensive high shear stress.  (Kittikunakorn, N., Sun, C. C., et al., 
2019). In this study, the polymorph transformation of GABA was investigated using FTIR (Hsu, 
C.-H., Ke, W.-T., & Lin, S.-Y., 2010). Polymorphic transformation of GABA was not observed 
for all melt-extruded granules prepared in this study (data was not presented). 
 However, due to high mechanical stresses during TSMG, the size reduction of GABA 
crystal was observed. In the Nano-16, the particle size reduction of GABA was dependent on 
DF. The higher DF was, the greater the reduction of GABA particle size was due to the 




of GABA is around 70 µm. At low DF (less than 20%), D50 of GABA did not change. However, 
at higher DF, D50 of GABA decreased to 10-20 µm. Above 20% DF, the threshold of crystal 
strength was reached, and there was no further decrease in GABA particle size. On the other 
hand, the reduction of GABA D50 was observed (D50 is between 10-20 µm) in all granules 
produced from the Micro-18 regardless of DF or SME. This indicated the high mixing efficiency 
of the kneading element in Micro-18, as compared to Nano-16 which relied on the high 
compaction force at high DF for granulation formation. The size reduction of GABA crystals 
generated the crystal defect or amorphous content in the melt-extruded granules, which 
subsequently accelerated the degradation of GABA. 
5.4.5    Physical properties of granules, Nano-16 vs. Micro-18 
The difference of granule formation mechanism between the Nano-16 and the Micro-18 
also affected the shape and tabletability of GABA granules. 
5.4.5.1  Granule shape 
As discussed in the previous section, the granulation mechanisms between the Nano-16 
and the Micro-18 are different. Granulation in the Nano-16 is dependent on the heating by the 
barrel and axial compaction. High DF is required to facilitate granule growth by improving 
Klucel melting and interactions between GABA and Klucel. As shown in Figure 5.9, 
enlargement of granules was observed when operated at low screw speed (high DF) in the Nano-
16. Fragmentation of granules occurred at higher screw speeds. Higher screw speeds led to lower 
DF as there is not enough material to be compacted to form granules. Therefore, smaller granules 
and fines were generated. 
In contrast, elongated granule shapes were observed in the Micro-18. With the increase in 
screw speed from 100 to 300 rpm, the granules became even more elongated, as indicated by the 
decrease of aspect ratio from 0.570 to 0.245. Unlike Nano-16, granule formation in the Micro-18 
occurred predominately via dispersive mixing of the kneading block, due to the restricted heat 
transfer from the barrel and the high efficiency of the dispersive mixing of kneading element. At 
higher screw speeds, the material was subjected to higher shear rate and higher SME. As a result, 
the formation of elongated granules was observed following the granulation. Similar results were 




granules were produced with increasing screw speeds. They hypothesized that this noodle-like 
shape of granules occurred by the rolling effect when the material was rolled at the interface 
between screw flight and the barrel surface which often arose after the material came out of the 




Figure 5.9  Images of melt-extruded granules processed with (A) Nano-16 extruder at given feed 
rate of 15 g/min and (B) Micro-18 extruder at the feed rate of 64 g/min with increasing screw 
speed (100, 150, 200, 300 rpm). *AR is aspect ratio, DFmax is maximum diameter, and DFmin is 
minimum diameter. 
5.4.5.2  Tabletability of GABA granules 
One of the primary objectives of granulation is to improve the tabletability of GABA by 
surface modification (Steffens & Wagner, 2019b). In our previous study, it was demonstrated 
that the improved tabletability of GABA was due to the enrichment of Klucel on GABA surface 










Figure 5.10  Correlation between process parameter and tensile strength of melt-extruded GABA 
tablets containing granules processed with (A) Nano-16 (B) Micro-18. 
Differences in screw geometry between the Nano-16 and the Micro-18 also affected the 
correlation between processing parameters and the tabletability. In the Nano-16, DF is the 
critical parameter affecting the granules’ tabletability. A minimal 15% DF was required to 
achieve 2MPa tensile strength, which is considered to be the target value for tableting (Osei-




significantly improve the tabletability (Figure 5.10A). The improved tabletability of granules can 
be explained by the granule formation mechanism. In the Nano-16, pre-granulation occurs even 
before the kneading section which is due to efficient heat transfer from the barrel that results in 
softening the Klucel. Consequently, high compaction force, which was a result of high DF, 
facilitates the spreading of Klucel on the GABA crystal surface, leading to improved 
tabletability. However, once the threshold DF was reached, the tabletability improvement was 





Figure 5.11  Binder distribution of melt-extruded GABA granules processed with Micro-18 at 
(A) high SME (0.18 kW.hr/kg, Run F16 in Table 5.2) and (B) low SME (0.06 kW.hr/kg,, Run 
F25 in Table 5.2). 
Improvement in the tabletability of GABA granules prepared using the Micro-18 was 
achieved under all conditions. Higher SME corresponded to better tabletability (Figure 5.10B). 




kneading blocks. Higher SME generated more mechanical energy to facilitate the Klucel 
spreading on the surface of GABA crystals.  Distribution patterns of Klucel in GABA granules 
processed at the highest (F16) and the lowest (F25) SME are presented in Figure 5.11. Granules 
were dispersed into the 20% sodium chloride solution in which GABA can be freely dissolved 
but Klucel cannot be dissolved. The remaining scaffold of Klucel was analyzed using phase-
contrast mode microscopy, and the data were processed and plotted using Image J. The Klucel 
scaffold in GABA granule F16 illustrated the continuous connection of Klucel spreading which 
attributed to the better improvement of tabletability. In contrast, the scaffold in GABA granule 
F25 showed discrete Klucel-rich and Klucel-poor phases, resulting in poor tabletability. 
5.5        CONCLUSION 
The effect of the different screw geometries on the physicochemical properties of 
granules was investigated using Leistritz Nano-16 and Micro-18 extruders. The dissimilarity of 
these two extruders exhibits the different granulation mechanisms and different correlations 
between process parameters and granule properties. For Nano-16, DF was a critical parameter, 
where higher DF led to higher degradant levels and more compressible granules.  For granules 
prepared using the Micro-18, SME was a critical parameter, where a higher SME led to higher 
degradant level and more compressible granules. The distinct behaviors call for close monitoring 
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